Marvell Technology (MRVL) 10-K13 Mar 242024 FY Annual reportFinancial data

Company Profile

Cover Page

Cover Page - USD ($) shares in Millions	12 Months Ended
Cover Page - USD ($) shares in Millions	Feb. 03, 2024	Mar. 06, 2024	Jul. 28, 2023
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--02-03
Document Period End Date	Feb. 03, 2024
Document Transition Report	false
Entity File Number	001-40357
Entity Registrant Name	MARVELL TECHNOLOGY, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3971597
Entity Address, Address Line One	1000 N. West Street, Suite 1200
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19801
City Area Code	302
Local Phone Number	295 - 4840
Title of 12(b) Security	Common stock, $0.002 par value per share
Trading Symbol	MRVL
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 55,800,186,642
Entity Common Stock, Shares Outstanding		866
Documents Incorporated by Reference	Portions of Part III of this Form 10-K are incorporated by reference from the registrant’s definitive proxy statement for its 2024 annual meeting of stockholders, which will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Form 10-K. Except with respect to information specifically incorporated by reference in this Form 10-K, the proxy statement is not deemed to be filed as part of this Form 10-K.
Entity Central Index Key	0001835632
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
Audit Information	Feb. 03, 2024
Auditor Information [Abstract]
Auditor Firm ID	34
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	San Jose, California

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Current assets:
Cash and cash equivalents	$ 950.8	$ 911
Accounts receivable, net	1,121.6	1,192.2
Inventories	864.4	1,068.3
Prepaid expenses and other current assets	125.9	109.6
Total current assets	3,062.7	3,281.1
Property and equipment, net	756	577.4
Goodwill	11,586.9	11,586.9
Acquired intangible assets, net	4,004.1	5,102
Deferred tax assets	311.9	465.9
Other non-current assets	1,506.9	1,508.8
Total assets	21,228.5	22,522.1
Current liabilities:
Accounts payable	411.3	465.8
Accrued liabilities	1,032.9	1,092
Accrued employee compensation	262.7	244.5
Short-term debt	107.3	584.4
Total current liabilities	1,814.2	2,386.7
Long-term debt	4,058.6	3,907.7
Other non-current liabilities	524.3	590.5
Total liabilities	6,397.1	6,884.9
Commitments and contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.002 par value; 8.0 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.002 par value; 1.3 billion shares authorized; 865.5 and 856.1 shares issued and outstanding in fiscal 2024 and 2023, respectively	1.7	1.7
Additional paid-in capital	14,845.3	14,512
Accumulated other comprehensive income	1.1	0
Retained earnings (Accumulated deficit)	(16.7)	1,123.5
Total stockholders’ equity	14,831.4	15,637.2
Total liabilities and stockholders’ equity	$ 21,228.5	$ 22,522.1

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Feb. 03, 2024	Jan. 28, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in usd per share)	$ 0.002	$ 0.002
Preferred stock, shares authorized (in shares)	8,000,000	8,000,000
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.002	$ 0.002
Common stock, shares authorized (in shares)	1,300,000,000	1,300,000,000
Common stock, shares issued (in shares)	865,500,000	856,100,000
Common stock, shares outstanding (in shares)	865,500,000	856,100,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Income Statement [Abstract]
Net revenue	$ 5,507.7	$ 5,919.6	$ 4,462.4
Cost of goods sold	3,214.1	2,932.1	2,398.2
Gross profit	2,293.6	2,987.5	2,064.2
Operating expenses:
Research and development	1,896.2	1,784.3	1,424.2
Selling, general and administrative	834	843.6	955.3
Legal settlement	0	100	0
Restructuring related charges	131.1	21.6	32.4
Total operating expenses	2,861.3	2,749.5	2,411.9
Operating income (loss)	(567.7)	238	(347.7)
Interest income	8.8	5.3	0.8
Interest expense	(211.7)	(170.6)	(139.3)
Other income, net	11.9	12.4	2.7
Interest and other loss, net	(191)	(152.9)	(135.8)
Income (loss) before income taxes	(758.7)	85.1	(483.5)
Provision (benefit) for income taxes	174.7	248.6	(62.5)
Net loss	$ (933.4)	$ (163.5)	$ (421)
Net loss per share - Basic (in dollars per share)	$ (1.08)	$ (0.19)	$ (0.53)
Net loss per share - Diluted (in dollars per share)	$ (1.08)	$ (0.19)	$ (0.53)
Weighted-average shares:
Basic (in shares)	861.3	851.4	796.9
Diluted (in shares)	861.3	851.4	796.9

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (933.4)	$ (163.5)	$ (421)
Other comprehensive income, net of tax:
Net change in unrealized gain on cash flow hedges	1.1	0	0
Other comprehensive income, net of tax	1.1	0	0
Comprehensive loss, net of tax	$ (932.3)	$ (163.5)	$ (421)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Restricted Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Restricted Stock	Accumulated Other Comprehensive Income	Retained Earnings (Accumulated Deficit)
Balance at beginning of period (in shares) at Jan. 30, 2021			675.4
Balance at beginning of period at Jan. 30, 2021	$ 8,435.8		$ 1.4	$ 6,331		$ 0	$ 2,103.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)			11.6
Issuance of common stock in connection with equity incentive plans	84.5			84.5
Tax withholdings related to net share settlement of restricted stock units	(299.9)	$ (299.9)
Stock-based compensation	$ 473.5			473.5
Repurchase of common stock (in shares)	0
Repurchase of common stock	$ 0
Issuance of common stock in connection with acquisitions (in shares)			146.2
Issuance of common stock in connection with acquisitions	6,890.1		$ 0.3	6,889.8
Equity related issuance cost	(8.2)			(8.2)
Replacement equity awards attributable to pre-acquisition service	115.6			115.6
Conversion feature of convertible notes	244.2			244.2
Impact of repurchase of convertible notes (in shares)			7.1
Impact of repurchase of convertible notes	234.3			234.3
Conversion of convertible notes to common stock (in shares)			6.4
Conversion of convertible notes to common stock	144.2			144.2
Cash dividends declared and paid	(191)						(191)
Net loss	(421)						(421)
Other comprehensive income	0
Balance at end of period (in shares) at Jan. 29, 2022			846.7
Balance at end of period at Jan. 29, 2022	15,702.1		$ 1.7	14,209		0	1,491.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)			11.7
Issuance of common stock in connection with equity incentive plans	91.3			91.3
Tax withholdings related to net share settlement of restricted stock units		(227.6)			$ (227.6)
Stock-based compensation	$ 554.3			554.3
Repurchase of common stock (in shares)	(2.3)		(2.3)
Repurchase of common stock	$ (115)			(115)
Cash dividends declared and paid	(204.4)						(204.4)
Net loss	(163.5)						(163.5)
Other comprehensive income	0
Balance at end of period (in shares) at Jan. 28, 2023			856.1
Balance at end of period at Jan. 28, 2023	15,637.2		$ 1.7	14,512		0	1,123.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)			11.9
Issuance of common stock in connection with equity incentive plans	99.2			99.2
Tax withholdings related to net share settlement of restricted stock units	(223.7)	$ (223.7)			$ (223.7)
Stock-based compensation	$ 607.8			607.8
Repurchase of common stock (in shares)	(2.5)		(2.5)
Repurchase of common stock	$ (150)			(150)
Cash dividends declared and paid	(206.8)						(206.8)
Net loss	(933.4)						(933.4)
Other comprehensive income	1.1					1.1
Balance at end of period (in shares) at Feb. 03, 2024			865.5
Balance at end of period at Feb. 03, 2024	$ 14,831.4		$ 1.7	$ 14,845.3		$ 1.1	$ (16.7)

CONSOLIDATED STATEMENTS OF ST_2

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Statement of Stockholders' Equity [Abstract]
Cash dividends declared (in dollars per share)	$ 0.24	$ 0.24	$ 0.24
Cash dividends paid (in dollars per share)	$ 0.24	$ 0.24	$ 0.24

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Cash flows from operating activities:
Net loss	$ (933,400)	$ (163,500)	$ (421,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	299,800	304,900	265,900
Stock-based compensation	609,800	552,400	460,700
Amortization of acquired intangible assets	1,097,900	1,087,400	979,400
Amortization of inventory fair value adjustment associated with acquisitions	0	38,700	194,300
Amortization of deferred debt issuance costs and debt discounts	10,700	10,300	21,600
Restructuring related impairment charges	32,900	5,600	6,200
Deferred income taxes	150,800	50,400	(93,900)
Other expense, net	44,200	52,400	69,000
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	70,600	(142,700)	(409,000)
Prepaid expenses and other assets	(93,100)	(480,400)	(161,800)
Inventories	201,900	(385,900)	(291,900)
Accounts payable	(149,100)	(87,800)	93,200
Accrued employee compensation	18,300	2,500	29,600
Accrued liabilities and other non-current liabilities	9,200	444,500	77,000
Net cash provided by operating activities	1,370,500	1,288,800	819,300
Cash flows from investing activities:
Purchases of technology licenses	(13,900)	(11,100)	(17,700)
Purchases of property and equipment	(336,300)	(206,200)	(169,200)
Acquisitions, net of cash acquired	0	(112,300)	(3,555,000)
Other, net	(300)	1,200	(3,200)
Net cash used in investing activities	(350,500)	(328,400)	(3,745,100)
Cash flows from financing activities:
Repurchases of common stock	(150,000)	(115,000)	0
Proceeds from employee stock plans	99,200	91,300	84,500
Tax withholding paid on behalf of employees for net share settlement	(223,700)	(227,600)	(305,800)
Dividend payments to stockholders	(206,800)	(204,400)	(191,000)
Payments on technology license obligations	(150,300)	(142,500)	(134,500)
Proceeds from borrowings	1,295,300	200,000	3,896,100
Principal payments of debt	(1,622,500)	(265,600)	(526,800)
Payment for repurchases and settlement of convertible notes	0	0	(181,200)
Proceeds from capped calls	0	0	160,300
Other, net	(21,400)	900	(10,800)
Net cash provided by (used in) in financing activities	(980,200)	(662,900)	2,790,800
Net increase (decrease) in cash and cash equivalents	39,800	297,500	(135,000)
Cash and cash equivalents at beginning of the year	911,000	613,500	748,500
Cash and cash equivalents at end of the year	$ 950,800	$ 911,000	$ 613,500

Basis of Presentation

Basis of Presentation	12 Months Ended
Basis of Presentation	Feb. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Company Marvell Technology, Inc., and its subsidiaries (the “Company”), is a leading supplier of data infrastructure semiconductor solutions, spanning the data center core to network edge. The Company is a fabless semiconductor supplier of high-performance standard and semi-custom products with core strengths in developing and scaling complex System-on-a-Chip architectures, integrating analog, mixed-signal and digital signal processing functionality. The Company also leverages leading intellectual property and deep system-level expertise, as well as highly innovative security firmware. The Company’s solutions are empowering the data economy and enabling the data center, enterprise networking, carrier infrastructure, consumer, and automotive/industrial end markets. The Company is incorporated in Delaware, United States. Basis of Presentation The Company’s fiscal year is the 52- or 53-week period ending on the Saturday closest to January 31. Accordingly, every fifth or sixth fiscal year will have a 53-week period. The additional week in a 53-week year is added to the fourth quarter, making such quarter consist of 14 weeks. Fiscal 2024 had a 53-week period. Fiscal 2023 and fiscal 2022 each had a 52-week period. Certain prior period amounts have been reclassified to conform to current year presentation. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Feb. 03, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provisions for sales returns and allowances, inventory excess and obsolescence, goodwill and other intangible assets, business combinations, restructuring, income taxes, litigation and other contingencies. Actual results could differ from these estimates, and such differences could affect the results of operations reported in future periods. In the current macroeconomic environment, these estimates could require increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, these estimates may change materially in future periods. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated. The functional currency of the Company and its subsidiaries is the U.S. dollar. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and time deposits. Investments in Equity Securities The Company has equity investments in privately-held companies. If the Company has the ability to exercise significant influence over the investee, but not control, the Company accounts for the investment under the equity method. If the Company does not have the ability to exercise significant influence over the operations of the investee, the Company accounts for the investment under the measurement alternative method. Investments in privately-held companies are included in other non-current assets and subject to impairment review on an ongoing basis. Investments are considered impaired when the fair value is below the investment’s cost basis. This assessment is based on a qualitative and quantitative analysis, including, but not limited to, the investee’s revenue and earnings trends, available cash and liquidity, and the status of the investee’s products and the related market for such products. Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to a significant concentration of credit risk consist principally of cash equivalents and accounts receivable. Cash and cash equivalents are maintained with high-quality financial institutions, the composition and maturities of which are regularly monitored by management. The Company believes that the concentration of credit risk in its trade receivables is substantially mitigated by the Company’s credit evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. For customers including distributors, the Company performs ongoing credit evaluations of their financial conditions and limits the amount of credit extended when deemed necessary based upon payment history and their current credit worthiness, but generally requires no collateral. The Company regularly reviews the allowance for bad debt and doubtful accounts by considering factors such as historical experience, credit quality, reasonable and supportable forecasts, age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay. The Company’s accounts receivable was concentrated with three customers at February 3, 2024, who comprise a total of 67% of gross accounts receivable, compared with five customers at January 28, 2023, who represented 55% of gross accounts receivable, respectively. This presentation is at the customer consolidated level. During fiscal 2024, 2023, and 2022, there was no net revenue attributable to a customer, other than one distributor, whose revenues as a percentage of net revenue was 10% or greater of total net revenues. Net revenue attributable to significant distributors whose revenues as a percentage of net revenue was 10% or greater of total net revenues is presented in the following table: Year Ended February 3, January 28, January 29, Distributor: Distributor A 24 % 20 % 15 % The Company continuously monitors the creditworthiness of its distributors and believes these distributors’ sales to diverse end customers and to diverse geographies further serve to mitigate the Company’s exposure to credit risk. Inventories Inventory is stated at the lower of cost or net realizable value, cost being determined under the first-in, first-out method. The total carrying value of the Company’s inventory is reduced for any difference between cost and estimated net realizable value of inventory that is determined to be excess, obsolete or unsellable inventory based upon assumptions about future demand and market conditions. If actual future demand for the Company’s products is less than currently forecasted, the Company may be required to write inventory down below the current carrying value. Once the carrying value of inventory is reduced, it is maintained until the product to which it relates is sold or otherwise disposed. Inventoriable shipping and handling costs are classified as a component of cost of goods sold in the consolidated statements of operations. Property and Equipment, Net Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which ranges from 2 to 7 years for machinery and equipment, and 3 to 4 years for computer software, and furniture and fixtures. Buildings are depreciated over an estimated useful life of 30 years and building improvements are depreciated over estimated useful lives of 15 years. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Goodwill Goodwill is recorded when the consideration paid for a business acquisition exceeds the fair value of net tangible and intangible assets acquired. Goodwill is measured and tested for impairment annually on the last business day of the fiscal fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or the Company may determine to proceed directly to the quantitative impairment test. If the Company assesses qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount or if the Company determines not to use the qualitative assessment, then a quantitative impairment test is performed. The quantitative impairment test requires comparing the fair value of the reporting unit to its carrying value, including goodwill. The Company has identified that its business operates as a single operating segment and as a single reporting unit for the purpose of goodwill impairment testing. An impairment exists if the fair value of the reporting unit is lower than its carrying value. If the fair value of the reporting unit is lower than its carrying value, the Company would record an impairment loss in the fiscal quarter in which the determination is made. Long-Lived Assets and Intangible Assets The Company assesses the impairment of long-lived assets and intangible assets whenever events or changes in circumstances indicate that the carrying amount of long-lived assets may not be recoverable. The Company estimates the future cash flows, undiscounted and without interest charges, expected to be generated by the assets from its use or eventual disposition. If the sum of the expected undiscounted future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Acquisition-related identified intangible assets are amortized on a straight-line basis over their estimated economic lives, except for certain customer contracts and related relationships, which are amortized using an accelerated method of amortization over the expected customer lives. In-process research and development (“IPR&D”) is not amortized until the completion of the related development. Leases The Company determines if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease ROU assets also include any initial direct costs and prepayments less lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. As the Company’s leases do not provide an implicit rate, the Company uses its collateralized incremental borrowing rate based on the information available at the lease commencement date, including lease term, in determining the present value of lease payments. Lease expense for these leases is recognized on a straight-line basis over the lease term. Foreign Currency Transactions The functional currency of all of the Company’s non-United States (“U.S.”) operations is the U.S. dollar. Monetary accounts maintained in currencies other than the U.S. dollar are re-measured using the foreign exchange rate at the balance sheet date. Operational accounts and nonmonetary balance sheet accounts are measured and recorded at the exchange rate in effect at the date of the transaction. The effects of foreign currency re-measurement are reported in current operations. Revenue Recognition Product revenue is recognized at a point in time when control of the asset is transferred to the customer. Substantially all of the Company’s revenue is derived from product sales. The Company recognizes revenue when it satisfies a performance obligation by transferring control of a product to a customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. For product revenue, the performance obligation is deemed to be the delivery of the product and therefore, the revenue is generally recognized upon shipment to customers, net of accruals for estimated sales returns and rebates. These estimates are based on historical returns, analysis of credit memo data and other known factors. The Company accounts for rebates by recording reductions to revenue for rebates in the same period that the related revenue is recorded. The amount of these reductions is based upon the terms agreed to with the customer. Product revenue on sales made to distributors is recognized upon shipment, net of estimated variable consideration. Variable consideration primarily consists of price discounts, price protection, rebates, and stock rotation programs and is estimated based on a portfolio approach using the expected value method derived from historical data, current economic conditions, and contractual terms. A portion of the Company’s net revenue is derived from sales through third-party logistics providers who maintain warehouses in close proximity to the Company’s customers’ facilities. Revenue from sales through these third-party logistics providers is not recognized until the product is pulled from stock by the customer. The Company’s products are generally subject to warranty, which provides for the estimated future costs of replacement upon shipment of the product. The Company generally warrants that its products sold to its customers will conform to its approved specifications and be free from defects in material and workmanship under normal use and conditions for one year. The Company may offer a longer warranty period in limited situations based on product type and negotiated warranty terms with certain customers. The warranty accrual is estimated primarily based on historical claims compared to historical revenues and assumes that the Company will have to replace products subject to a claim. From time to time, the Company becomes aware of specific warranty situations, and it records specific accruals to cover these exposures. Business Combinations The Company allocates the fair value of the purchase consideration of its business acquisitions to the tangible assets, liabilities, and intangible assets acquired, including IPR&D, based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life. Acquisition-related expenses and related restructuring costs are recognized separately from the business combination and are expensed as incurred. Stock-Based Compensation Stock-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as expense over the requisite service vesting period. The Company amortizes stock-based compensation expense for time-based awards under the straight-line attribution method over the vesting period. Stock-based compensation expense for performance-based awards is recognized when it becomes probable that the performance conditions will be met. The Company amortizes stock-based compensation expense for performance-based awards using the accelerated method. The fair value of each restricted stock unit is estimated based on the market price of the Company’s common stock on the date of grant less the expected dividend yield. The Company estimates the fair value of stock purchase awards on the date of grant using the Black Scholes option-pricing model. The fair value of performance-based awards based on total shareholder return (“TSR”) are estimated on the date of grant using a Monte Carlo simulation model. Forfeitures are recorded when they occur. Previously recognized expense is reversed for the portion of awards forfeited prior to vesting as and when forfeitures occur. Comprehensive Loss Comprehensive loss, net of tax is comprised of net loss and net change in unrealized gains and losses, on cash flow hedges for fiscal 2024. For fiscal 2023 and 2022, there were no reconciling differences between net loss and comprehensive loss. Accounting for Income Taxes The Company estimates its income taxes in the jurisdictions in which it operates. This process involves estimating the Company’s actual tax expense together with assessing temporary differences resulting from the differing treatment of certain items for tax return and financial statement purposes. These differences result in deferred tax assets and liabilities, which are included in the Company’s consolidated balance sheets. The Company recognizes income taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year, and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law and the effects of future changes in tax laws or rates are not anticipated. Evaluating the need for a valuation allowance for deferred tax assets requires judgment and analysis of all available positive and negative evidence, including recent earnings history and cumulative losses in recent years, reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies to determine whether all or some portion of the deferred tax assets will not be realized. Forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence such as cumulative losses in recent years. Using available evidence and judgment, the Company establishes a valuation allowance for deferred tax assets, when it is determined that it is more likely than not that they will not be realized. Valuation allowances have been provided primarily against U.S. federal and state research and development credits and certain acquired net operating losses and deferred tax assets of foreign subsidiaries. A change in the assessment of the realizability of deferred tax assets may materially impact the Company’s tax provision in the period in which a change of assessment occurs. Taxes due on Global Intangible Low-Taxed Income (“GILTI”) inclusions in U.S. are recognized as a current period expense when incurred. As a multinational corporation, the Company conducts its business in many countries and is subject to taxation in many jurisdictions. The taxation of the business is subject to the application of various and sometimes conflicting tax laws and regulations as well as multinational tax conventions. The Company’s effective tax rate is highly dependent upon the geographic distribution of the Company’s worldwide earnings or losses, the tax laws and regulations in various jurisdictions, the availability of tax incentives, tax credits and loss carryforwards, and the effectiveness of the Company’s tax planning strategies, including the Company’s estimates of the fair value of its intellectual property. The application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty. Tax laws themselves are subject to change as a result of changes in fiscal policy, changes in legislation, and the evolution of regulations and court rulings and tax audits. There can be no assurance that the Company will accurately predict the outcome of audits, and the amounts ultimately paid on resolution of audits could be materially different than the amounts previously included in the Company’s income tax expense and therefore, could have a material impact on its tax provision, results of operations, and cash flows. Consequently, taxing authorities may impose tax assessments or judgments against us that could materially impact the Company’s tax liability and/or its effective income tax rate. The Company is subject to income tax audits by the respective tax authorities in the jurisdictions in which it operates. The Company recognizes the effect of income tax positions only if these positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is more than 50% likely to be realized. Changes in judgment regarding the recognition or measurement of uncertain tax positions are reflected in the period in which the change occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense. The calculation of the Company’s tax liabilities involves the inherent uncertainty associated with complex tax laws. The Company believes it has adequately provided for in its financial statements additional taxes that it estimates may be required to be paid as a result of such examinations. While the Company believes that it has adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than its accrued position. Unpaid tax liabilities, including the interest and penalties, are released pursuant to a final settlement with tax authorities, completion of audit or expiration of various statutes of limitations. The material jurisdictions in which the Company may be subject to examination by tax authorities throughout the world include China, India, Israel, Singapore, Germany, and the United States. The recognition and measurement of current taxes payable or refundable, and deferred tax assets and liabilities require that the Company make certain estimates and judgments. Changes to these estimates or judgments may have a material effect on the Company’s tax provision in a future period. Recent Accounting Pronouncements Accounting Pronouncements Not Yet Effective In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280) to improve reportable segment disclosures. The update requires disclosure of incremental segment information on an annual and interim basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) to improve income tax disclosures to enhance transparency and decision usefulness of income tax disclosure. The ASU is effective for fiscal years beginning after December 15, 2024 with updates to be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements.

Revenue

Revenue	12 Months Ended
Revenue	Feb. 03, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The majority of the Company’s revenue is generated from sales of the Company’s products. The following table summarizes net revenue disaggregated by end market (in millions, except percentages): Year Ended February 3, 2024 % of Total Year Ended January 28, 2023 % of Total Year Ended January 29, 2022 % of Total Net revenue by end market: Data center $ 2,216.7 40 % $ 2,408.8 41 % $ 1,784.7 40 % Enterprise networking 1,228.4 22 % 1,369.2 23 % 907.7 20 % Carrier infrastructure 1,051.9 19 % 1,084.0 18 % 820.4 18 % Consumer 622.4 11 % 701.1 12 % 700.0 16 % Automotive/industrial 388.3 8 % 356.5 6 % 249.6 6 % $ 5,507.7 $ 5,919.6 $ 4,462.4 The following table summarizes net revenue disaggregated by primary geographical market based on destination of shipment (in millions, except percentages): Year Ended February 3, 2024 % of Total Year Ended January 28, 2023 % of Total Year Ended January 29, 2022 % of Total Net revenue based on destination of shipment: China $ 2,371.0 43 % $ 2,486.3 42 % $ 1,970.5 44 % United States 795.6 14 % 690.1 12 % 484.0 11 % Finland 380.4 7 % 189.6 3 % 80.2 2 % Singapore 336.2 6 % 331.7 6 % 220.8 5 % Thailand 329.2 6 % 391.9 7 % 355.3 8 % Malaysia 222.6 4 % 393.2 7 % 276.0 6 % Japan 169.1 3 % 260.0 4 % 222.8 5 % Taiwan 161.9 3 % 289.0 5 % 161.0 4 % Philippines 74.6 1 % 171.5 3 % 213.4 5 % Others 667.1 13 % 716.3 11 % 478.4 10 % $ 5,507.7 $ 5,919.6 $ 4,462.4 These destinations of shipment are not necessarily indicative of the geographic location of the Company’s end customers or the country in which the Company’s end customers sell devices containing the Company’s products. For example, a substantial majority of the shipments made to China relate to sales to non-China based customers that have factories or contract manufacturing operations located within China. The following table summarizes net revenue disaggregated by customer type (in millions, except percentages): Year Ended February 3, 2024 % of Total Year Ended January 28, 2023 % of Total Year Ended January 29, 2022 % of Total Net revenue by customer type: Direct customers $ 3,469.5 63 % $ 3,949.6 67 % $ 3,314.5 74 % Distributors 2,038.2 37 % 1,970.0 33 % 1,147.9 26 % $ 5,507.7 $ 5,919.6 $ 4,462.4 Contract Liabilities Contract liabilities consist of the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration or the amount is due from the customer. Contract liability balances are comprised of deferred revenue. The amount of revenue recognized during the year ended February 3, 2024, that was included in deferred revenue balance at January 28, 2023 was not material. As of the end of a reporting period, some of the performance obligations associated with contracts will have been unsatisfied or only partially satisfied. In accordance with the practical expedients available in the guidance, the Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less. Sales Commissions The Company has elected to apply the practical expedient to expense commissions when incurred as the amortization period is typically one year or less. These costs are recorded in selling, general and administrative expenses in the consolidated statements of operations.

Debt

Debt	12 Months Ended
Debt	Feb. 03, 2024
Debt Disclosure [Abstract]
Debt	Debt Summary of Borrowings and Outstanding Debt The following table summarizes the Company’s outstanding debt at February 3, 2024 and January 28, 2023 (in millions): February 3, January 28, Face Value Outstanding: 2024 Term Loan - 3-Year Tranche $ — $ 735.0 2026 Term Loan - 5-Year Tranche 700.0 787.5 Term Loan Total 700.0 1,522.5 4.200% MTG/MTI 2023 Senior Notes — 500.0 4.875% MTG/MTI 2028 Senior Notes 499.9 499.9 1.650% 2026 Senior Notes 500.0 500.0 2.450% 2028 Senior Notes 750.0 750.0 5.750% 2029 Senior Notes 500.0 — 2.950% 2031 Senior Notes 750.0 750.0 5.950% 2033 Senior Notes 500.0 — Senior Notes Total 3,499.9 2,999.9 Total borrowings $ 4,199.9 $ 4,522.4 Less: Unamortized debt discount and issuance cost (34.0) (30.3) Net carrying amount of debt $ 4,165.9 $ 4,492.1 Less: Current portion (1) 107.3 584.4 Non-current portion $ 4,058.6 $ 3,907.7 (1) As of February 3, 2024, the current portion of outstanding debt that is due within twelve months includes a portion of the 2026 Term Loan - 5-Year Tranche. The weighted-average interest rate on short-term debt outstanding at February 3, 2024 and January 28, 2023 was 6.830% and 4.448%, respectively. 2024 and 2026 Term Loans On December 7, 2020, the Company entered into a term loan credit agreement with a lending syndicate led by JP Morgan Chase Bank, N.A (the “2024 and 2026 Term Loan Agreement”) in order to finance the acquisition of Inphi Corporation (“Inphi”). The 2024 and 2026 Term Loan Agreement provides for borrowings of $1.8 billion consisting of: (i) $875.0 million loan with a 3-year term from the funding date (the “3-Year Tranche Loan”) and (ii) $875.0 million loan with a 5-year term from the funding date (the “5-Year Tranche Loan” and, together with the 3-Year Tranche Loan, the “2024 and 2026 Term Loans”). On April 14, 2023, the Company entered into an amendment to the 2024 and 2026 Term Loan Agreement. The amendment modifies the existing agreement to, among other things, adopt Secured Overnight Financing Rate (“SOFR”) interest rates and conform the maximum leverage ratio financial covenant with the amended and restated revolving credit agreement. The 3-Year Tranche Loan, due on April 19, 2024, which had a remaining principal of $735.0 million, was repaid in full during the quarter ended October 28, 2023. Pursuant to the amended 2024 and 2026 Term Loan Agreement, the 5-Year Tranche Loan has a stated floating interest rate which equates to adjusted term SOFR + 137.5 bps. The effective interest rate for the 5-Year Tranche Loan was 5.111% as of February 3, 2024. The 5-Year Tranche Loan requires scheduled principal payments at the end of each fiscal quarter equal to (i) 1.25% of the aggregate principal amount on the term funding date for the first four full fiscal quarters following the term loan funding date, (ii) 2.50% of the aggregate principal amount on the term funding date for the fifth through twelfth full fiscal quarters following the term loan funding date, and (iii) 3.75% of the aggregate principal amount on the term funding date for each fiscal quarter following the twelfth full fiscal quarter following the term loan funding date. During the year ended February 3, 2024, the Company repaid $87.5 million of the principal outstanding of the 5-Year Tranche Loan. As of February 3, 2024, the Company has $700.0 million of 5-Year Tranche Loan borrowings outstanding. The 2024 and 2026 Term Loan Agreement requires that the Company and its subsidiaries comply with covenants relating to customary matters, including with respect to creating or permitting certain liens, entering into sale and leaseback transactions, and consolidating, merging, liquidating or dissolving. It also prohibits subsidiaries of the Company from incurring additional indebtedness, subject to certain exceptions, and requires that the Company maintain a leverage ratio financial covenant as of the end of any fiscal quarter. 2023 Revolving Credit Facility On December 7, 2020, the Company entered into a revolving line of credit agreement with a lending syndicate led by JP Morgan Chase Bank, N.A for borrowings of up to $750.0 million. On April 14, 2023, the Company entered into an agreement to amend and restate the credit facility to increase the borrowing capacity to $1.0 billion (as so amended and restated, the “2023 Revolving Credit Facility”). The 2023 Revolving Credit Facility has a 5-year term and a stated floating interest rate which equates to an adjusted term SOFR plus an applicable margin. The borrowings from the Revolving Loans will be used for general corporate purposes of the Company. The Company may prepay any borrowings at any time without premium or penalty. An unused commitment fee is payable quarterly based on unused balances at a rate that is based on the ratings of the Company’s senior unsecured long-term indebtedness. This annual rate was 0.175% at February 3, 2024. During the quarter ended April 29, 2023, the Company drew down $200.0 million on the 2023 Revolving Credit Facility. During the quarter ended July 29, 2023, the Company drew down $50.0 million on the 2023 Revolving Credit Facility and repaid $50.0 million in the same quarter. During the quarter ended October 28, 2023, the Company repaid $200.0 million of the 2023 Revolving Credit Facility which was outstanding from the first quarter of fiscal 2024 and also drew down and repaid an additional $50.0 million from the 2023 Revolving Credit Facility. As of February 3, 2024, the 2023 Revolving Credit Facility was undrawn and will be available for draw down through April 14, 2028 . The 2023 Revolving Credit Facility requires that the Company and its subsidiaries comply with covenants relating to customary matters. The covenants are consistent with the 2024 and 2026 Term Loan covenants discussed above. As of February 3, 2024 , the Company was in compliance with its debt covenants for the credit agreements discussed above. 2029 and 2033 Senior Unsecured Notes On September 18, 2023, the Company completed an offering of (i) $500.0 million aggregate principal amount of the Company’s 5.750% Senior Notes due 2029 (the “2029 Senior Notes”) and (ii) $500.0 million aggregate principal amount of the Company’s 5.950% Senior Notes due 2033 (the “2033 Senior Notes”, and, together with the 2029 Senior Notes, the “2029 and 2033 Senior Notes”). The 2029 Senior Notes have a 5.5-year term and mature on February 15, 2029, and the 2033 Senior Notes have a 10-year term and mature on September 15, 2033. The stated and effective interest rates for the 2029 Senior Notes are 5.750% and 5.891%, respectively. The stated and effective interest rates for the 2033 Senior Notes are 5.950% and 6.082%, respectively. The Company may redeem the 2029 and 2033 Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in 2029 and 2033 Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the 2029 and 2033 Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the 2029 and 2033 Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2029 and 2033 Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. As of February 3, 2024 , the Company had $1.0 billion borrowings outstanding from 2029 and 2033 Senior Notes. 2026, 2028 and 2031 Senior Unsecured Notes On April 12, 2021, the Company completed an offering of (i) $500.0 million aggregate principal amount of the Company’s 1.650% Senior Notes due 2026 (the “2026 Senior Notes”), (ii) $750.0 million aggregate principal amount of the Company’s 2.450% Senior Notes due 2028 (the “2028 Senior Notes”) and (iii) $750.0 million aggregate principal amount of the Company’s 2.950% Senior Notes due 2031 (the “2031 Senior Notes”, and, together with the 2026 Senior Notes and the 2028 Senior Notes, the “2026, 2028 and 2031 Senior Notes”). On October 8, 2021, the 2026, 2028 and 2031 Senior Notes issued on April 12, 2021 were exchanged for new notes. The terms of the new notes issued in the exchange are substantially identical to the notes issued in April 2021, except that the new notes are registered under the Securities Act of 1933, as amended (the “Securities Act”) and the transfer restrictions and registration rights applicable to the 2026, 2028 and 2031 Senior Notes issued in April 2021 do not apply to the new notes. The 2026 Senior Notes have a 5-year term and mature on April 15, 2026, the 2028 Senior Notes have a 7-year term and mature on April 15, 2028, and the 2031 Senior Notes have a 10-year term and mature on April 15, 2031. The stated and effective interest rates for the 2026 Senior Notes are 1.650% and 1.839%, respectively. The stated and effective interest rates for the 2028 Senior Notes are 2.450% and 2.554%, respectively. The stated and effective interest rates for the 2031 Senior Notes are 2.950% and 3.043%, respectively. The Company may redeem the 2026, 2028 and 2031 Senior Notes, in whole or in part, at any time prior to their respective maturity at the redemption prices set forth in the indenture governing the 2026, 2028 and 2031 Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the 2026, 2028 and 2031 Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the 2026, 2028 and 2031 Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2026, 2028 and 2031 Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. As of February 3, 2024, the Company had $2.0 billion borrowings outstanding from 2026, 2028 and 2031 Senior Notes. 2023 and 2028 Senior Unsecured Notes On June 22, 2018, the Company’s Bermuda-based parent company Marvell Technology Group, Ltd. (“MTG”) completed a public offering of (i) $500.0 million aggregate principal amount of 4.200% Senior Notes due 2023 (the “MTG 2023 Notes”) and (ii) $500.0 million aggregate principal amount of 4.875% Senior Notes due 2028 (the “MTG 2028 Notes” and, together with the MTG 2023 Notes, the “MTG Senior Notes”). In April 2021, in conjunction with the Company’s U.S. domiciliation, the Company commenced Exchange Offers on April 19, 2021 for the outstanding $1.0 billion in aggregate principal amount of the MTG Senior Notes outstanding in exchange for corresponding senior notes to be issued by the Company’s U.S. domiciled parent MTI. MTI made an offer to (i) exchange any and all of the outstanding MTG 2023 Notes for up to an aggregate principal amount of $500.0 million of new 4.200% Senior Notes due 2023 issued by MTI (the “MTI 2023 Notes”) and to (ii) exchange any and all of the outstanding MTG 2028 Notes for up to an aggregate principal amount of $500.0 million of new 4.875% Senior Notes due 2028 issued by MTI (the “MTI 2028 Notes” and, together with the MTI 2023 Notes, the “MTI Senior Notes”). Each new series of MTI Senior Notes have the same interest rate, maturity date, redemption terms and interest payment dates and are subject to substantially similar covenants as the corresponding series of the MTG Senior Notes for which they were offered in exchange. The settlement of the Exchange Offers occurred on May 4, 2021 with $433.9 million aggregate principal amount of the MTG 2023 Notes and $479.5 million aggregate principal amount of the MTG 2028 Notes. The exchange was accounted for as a debt modification in accordance with applicable accounting guidance. On December 16, 2021, the MTI Senior Notes issued on May 4, 2021 were exchanged for new notes. The terms of the new notes issued in the exchange are substantially identical to the notes issued in May 2021, except that the new notes are registered under the Securities Act and the transfer restrictions and registration rights applicable to the MTI Senior Notes issued in May 2021 do not apply to the new notes. The MTI 2023 Notes and MTG 2023 Notes with aggregate principal of $500.0 million matured on June 22, 2023 and was repaid. The MTI 2028 Notes mature on June 22, 2028. The stated and effective interest rates for the MTI 2028 Notes are 4.875% and 4.988%, respectively. The Company may redeem the MTI Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in MTI Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the MTI Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the MTI Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the MTI Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. The MTG 2028 Notes mature on June 22, 2028. The stated and effective interest rates for the MTG 2028 Notes are 4.875% and 4.940%, respectively. The Company may redeem the MTG Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in MTG Senior Notes. As of February 3, 2024, the Company had $499.9 million borrowings outstanding from MTI 2028 Notes and MTG 2028 Notes. Interest Expense and Future Contractual Maturities During fiscal 2024, fiscal 2023, and fiscal 2022, the Company recognized $202.9 million, $159.6 million, and $119.0 million of interest expense, respectively, in its consolidated statements of operations related to interest, amortization of debt issuance costs and accretion of discount associated with the outstanding term loans and senior notes. As of February 3, 2024, the aggregate future contractual maturities of the Company’s outstanding debt, at face value, were as follows (in millions): Fiscal Year Amount 2025 $ 109.4 2026 131.2 2027 959.4 2028 — 2029 1,249.9 Thereafter 1,750.0 Total $ 4,199.9

Leases

Leases	12 Months Ended
Leases	Feb. 03, 2024
Leases [Abstract]
Leases	Leases The Company’s leases primarily include facility leases and hosting/data center leases, which are all classified as operating leases. For hosting/data center leases, the Company elected the practical expedient to account for the lease and non-lease component as a single lease component. Lease expense and supplemental cash flow information are as follows (in millions): Year Ended February 3, January 28, January 29, Operating lease expense $ 62.0 $ 49.6 $ 61.7 Cash paid for amounts included in the measurement of operating lease liabilities $ 53.5 $ 41.9 $ 45.1 Right-of-use assets obtained in exchange for lease obligation $ 34.1 $ 107.7 $ 95.4 The effect of operating lease right-of-use asset amortization of $37.2 million, $32.5 million and $28.9 million is included in changes in Other expense, net in the cash provided by operating activities section on the consolidated statements of cash flows for the fiscal years ended February 3, 2024, January 28, 2023, and January 29, 2022, respectively. The aggregate future lease payments for operating leases as of February 3, 2024 are as follows (in millions): Fiscal Year Operating Leases Sublease Income 2025 $ 47.8 $ 5.5 2026 43.4 5.7 2027 39.7 5.9 2028 33.1 4.1 2029 23.7 2.2 Thereafter 86.7 4.1 Total lease payments 274.4 27.5 Less: imputed interest 39.0 Present value of lease liabilities $ 235.4 Average lease terms and discount rates were as follows: February 3, January 28, Weighted-average remaining lease term (years) 7.3 7.0 Weighted-average discount rate 4.0 % 3.7 %

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Feb. 03, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Warranty Obligations The Company generally warrants that its products sold to its customers will conform to its approved specifications and be free from defects in material and workmanship under normal use and conditions for one year. The Company may offer a longer warranty period in limited situations based on product type and negotiated warranty terms with certain customers. Commitments The Company’s commitments primarily consist of wafer purchase obligations with foundry partners, supply capacity reservation payment commitments with foundries and test & assembly partners, and technology license fee obligations. Total future unconditional purchase commitments as of February 3, 2024, are as follows (in millions): Fiscal Year Purchase Commitments to Technology 2025 $ 820.5 $ 149.9 2026 517.0 75.5 2027 374.6 39.2 2028 185.5 36.7 2029 139.3 38.7 Thereafter 394.2 118.2 Total unconditional purchase commitments $ 2,431.1 $ 458.2 Technology license fees include the liabilities under agreements for technology licenses between the Company and various vendors. Under the Company’s manufacturing relationships with its foundry partners, cancellation of outstanding purchase orders is allowed but requires payment of all costs and expenses incurred through the date of cancellation, and in some cases, may result in incremental fees, loss of amounts paid in advance, or loss of priority to reserved capacity for a period of time. The Company entered into manufacturing supply capacity reservation agreements with foundries and test & assembly suppliers during the current and prior fiscal year. Under these arrangements, the Company agreed to pay capacity fees or refundable deposits to the suppliers in exchange for reserved manufacturing production capacity over the term of the agreements, which ranges from 4 to 10 years. In addition, the Company committed to certain purchase levels that were in line with the capacity reserved. The Company currently estimates that it has agreed to purchase level commitments of at least $2.0 billion of wafers, substrates, and other manufacturing products for fiscal 2025 through 2033 under the capacity reservation agreements. In addition, t otal fees and refundable deposits payable under these arrangements are $86.0 million in fiscal 2025 through 2026 . Such purchase commitments are summarized in the preceding table. In September 2021, the Company entered into an IP licensing agreement with a vendor which provides complete access to the vendor’s IP portfolio for 10 years . The arrangement provides access to IP over the term of the contract, including existing IP, as well as IP in development, and to be developed in the future. The contract provides support and maintenance over the term of the contract as well. Aggregate fees of $354.0 million are payable quarterly over the contract term. Contingencies and Legal Proceedings The Company currently is, and may from time to time become, subject to claims, lawsuits, governmental inquiries, inspections or investigations and other legal proceedings (collectively, “Legal Matters”) arising in the course of its business. Such Legal Matters, even if not meritorious, could result in the expenditure of significant financial and managerial resources. During the third quarter of fiscal 2023, the Company entered into a settlement agreement with a customer in relation to a contractual dispute pursuant to which the Company agreed to pay the customer $100.0 million over several quarters. The amount has been paid in full. As of the end of fiscal 2024, the Company recognized charges of $251.0 million in the aggregate for product related claims, including amounts recognized in previous quarters. Such claims were fully resolved in the fourth quarter of fiscal 2024. The Company is currently unable to predict the final outcome of its pending Legal Matters and therefore cannot determine the likelihood of loss or estimate a range of possible loss, except with respect to amounts where it has determined a loss is both probable and estimable and has made an accrual. The Company evaluates, at least on a quarterly basis, developments in its Legal Matters that could affect the amount of any accrual, as well as any developments that would result in a loss contingency to become both probable and reasonably estimable. The ultimate outcome of a Legal Matter involves judgments, estimates and inherent uncertainties. An unfavorable outcome in a Legal Matter could require the Company to pay damages or could prevent the Company from selling some of its products in certain jurisdictions. While the Company cannot predict with certainty the results of the Legal Matters in which it is currently involved, the Company does not expect that the ultimate costs to resolve these Legal Matters will individually or in the aggregate have a material adverse effect on its financial condition, however, there can be no assurance that the current or any future Legal Matters will be resolved in a manner that is not adverse to the Company’s business, financial statements, results of operations or cash flows. Indemnities, Commitments and Guarantees During its normal course of business, the Company has made certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. These indemnities may include indemnities for general commercial obligations, indemnities to various lessors in connection with facility leases for certain claims arising from such facility or lease, and indemnities to directors and officers of the Company to the maximum extent permitted under the laws of Delaware. In addition, the Company has contractual commitments to various customers, which could require the Company to incur costs to repair an epidemic defect with respect to its products outside of the normal warranty period if such defect were to occur. The duration of these indemnities, commitments and guarantees varies, and in certain cases, is indefinite. Some of these indemnities, commitments and guarantees do not provide for any limitation of the maximum potential future payments that the Company could be obligated to make. In general, the Company does not record any liability for these indemnities, commitments and guarantees in the accompanying consolidated balance sheets as the amounts cannot be reasonably estimated and are not considered probable. The Company does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and estimable. Intellectual Property Indemnification In addition to the above indemnities, the Company has agreed to indemnify certain customers for claims made against the Company’s products where such claims allege infringement of third-party intellectual property rights, including, but not limited to, patents, registered trademarks, and/or copyrights. Under the aforementioned indemnification clauses, the Company may be obligated to defend the customer and pay for the damages awarded against the customer as well as the attorneys’ fees and costs under an infringement claim. The Company’s indemnification obligations generally do not expire after termination or expiration of the agreement containing the indemnification obligation. Generally, but not always, there are limits on and exceptions to the Company’s potential liability for indemnification. Historically the Company has not made significant payments under these indemnification obligations and the Company cannot estimate the amount of potential future payments, if any, that it might be required to make as a result of these agreements. The maximum potential amount of any future payments that the Company could be required to make under these indemnification obligations could be significant.

Business Combinations

Business Combinations	12 Months Ended
Business Combinations	Feb. 03, 2024
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Innovium On October 5, 2021, the Company completed the acquisition of Innovium, Inc. (“Innovium”), a leading provider of networking solutions for cloud and edge data centers, in an all-stock transaction for total purchase consideration of $1.0 billion attributable to stock consideration of $994.2 million and the fair value of a previously held equity interest of $10.0 million. The Innovium acquisition was primarily intended to allow the Company to immediately participate in the fastest growing segment of the switch market with a cloud-optimized solution. In accordance with the terms of the Agreement and Plan of Merger dated August 2, 2021 (the “Innovium merger agreement”), the Company’s common stock was issued in exchange for all outstanding equity of Innovium, including shares of Innovium’s preferred and common stock, employee equity awards and warrants. The factors contributing to the recognition of goodwill were based upon the Company’s conclusion that there are strategic and synergistic benefits that are expected to be realized from the acquisition. Goodwill recorded for the Innovium acquisition is not expected to be deductible for tax purposes. The following table summarized the total merger consideration (in millions): Common stock issued or to be issued $ 971.0 Stock consideration for replacement equity awards attributable to pre-combination service 33.2 Total merger consideration $ 1,004.2 In accordance with U.S. GAAP requirements for business combinations, the Company allocated the fair value of the purchase consideration to the tangible assets, liabilities and intangible assets acquired, including in-process research and development (“IPR&D”), generally based on their estimated fair values. The excess purchase price over those fair values is recorded as goodwill. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life. The Company’s valuation assumptions of acquired assets and assumed liabilities require significant estimates, especially with respect to intangible assets. Acquisition-related costs are expensed in the periods in which such costs are incurred. See “Note 8 – Goodwill and Acquired Intangible Assets, Net” for additional information. The purchase price allocation is as follows (in millions): Cash and cash equivalents $ 60.4 Inventories 70.0 Goodwill 462.4 Acquired intangible assets, net 433.0 Other, net (21.6) Total merger consideration $ 1,004.2 The Company incurred total acquisition related costs of $11.9 million which were recorded in selling, general and administrative expense in the consolidated statements of operations. Inphi On April 20, 2021, the Company completed the acquisition of Inphi (the “Inphi acquisition”). Inphi is a global leader in high-speed data movement enabled by optical interconnects. The Inphi acquisition was primarily intended to create an opportunity for the combined company to be uniquely positioned to serve the data-driven world, addressing high growth, attractive end markets such as cloud data center and 5G. In accordance with the terms of the Agreement and Plan of Merger dated as of October 29, 2020, by and among the Company and Inphi (the “Inphi merger agreement”), the Company acquired all outstanding shares of common stock of Inphi for $66.00 per share in cash and 2.323 shares of the Company’s common stock exchanged for each share of Inphi common stock. The merger consideration paid in cash was funded with a combination of cash on hand and funds from the Company’s debt financing. See “Note 4 – Debt” for additional information. The factors contributing to the recognition of goodwill were based upon the Company’s conclusion that there are strategic and synergistic benefits that are expected to be realized from the acquisition. Goodwill recorded for the Inphi acquisition is not expected to be deductible for tax purposes. The following table summarized the total merger consideration (in millions): Cash consideration $ 3,673.2 Common stock issued 5,917.8 Stock consideration for replacement equity awards attributable to pre-combination service 82.3 Equity component of convertible debt 244.2 Total merger consideration $ 9,917.5 In accordance with U.S. GAAP requirements for business combinations, the Company allocated the fair value of the purchase consideration to the tangible assets, liabilities and intangible assets acquired, including IPR&D, generally based on their estimated fair values. The excess purchase price over those fair values is recorded as goodwill. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life. The Company’s valuation assumptions of acquired assets and assumed liabilities require significant estimates, especially with respect to intangible assets. Acquisition-related costs are expensed in the periods in which such costs are incurred. See “Note 8 – Goodwill and Acquired Intangible Assets, Net” for additional information. The purchase price allocation is as follows (in millions): Cash and cash equivalents $ 72.3 Accounts receivable, net 99.7 Inventories 270.4 Prepaid expenses and other current assets 213.3 Property and equipment, net 98.5 Acquired intangible assets, net 4,420.0 Other non-current assets 96.6 Goodwill 5,688.4 Accounts payable and accrued liabilities (189.8) Convertible debt - short-term (313.7) Convertible debt - long-term (240.3) Other non-current liabilities (297.9) Total merger consideration $ 9,917.5 In fiscal 2022, the Company incurred $50.8 million in acquisition related costs which were recorded in selling, general and administrative expense in the consolidated statements of operations. The Company also incurred $39.8 million of aggregate debt financing costs. As of February 3, 2024, $2.1 million is included in short-term debt, and $15.2 million is included in long-term debt on the accompanying consolidated balance sheets. See “Note 4 – Debt” for additional information. Additionally, the Company incurred $8.2 million of equity issuance costs, which were recorded in additional paid-in capital in the consolidated balance sheets. Unaudited Supplemental Pro Forma Information The unaudited supplemental pro forma financial information presented below is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the acquisitions had been completed on the date indicated, does not reflect synergies that might have been achieved, nor is it indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions the Company believe are reasonable under the circumstances. The following unaudited supplemental pro forma information presents the combined results of operations for fiscal 2022, as if Innovium and Inphi had been acquired as of beginning of fiscal 2021. The unaudited supplemental pro forma information includes adjustments to amortization and depreciation for acquired intangible assets and property and equipment, adjustments to stock-based compensation expense, the purchase accounting effect on inventories acquired, interest expense, and transaction costs. For fiscal 2021, non-recurring pro forma adjustments directly attributable to the Innovium and Inphi acquisitions in the pro forma information presented below included (i) stock-based compensation expense of $46.7 million, (ii) the purchase accounting effect of inventories acquired of $233.0 million, (iii) interest expense of $11.4 million, and (iv) transaction costs of $65.7 million. The unaudited supplemental pro forma information presented below is for informational purposes only and is not necessarily indicative of the Company’s consolidated results of operations of the combined business had the Inphi and Innovium acquisitions actually occurred at the beginning of fiscal 2021 or of the results of the Company’s future operations of the combined business. The unaudited supplemental pro forma financial information for the periods presented is as follows (in millions): Year Ended January 29, Pro forma net revenue $ 4,638.5 Pro forma net loss $ (211.9)

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets, Net	12 Months Ended
Goodwill and Acquired Intangible Assets, Net	Feb. 03, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets, Net	Goodwill and Acquired Intangible Assets, Net Goodwill Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. In connection with the Innovium and Inphi acquisitions on October 5, 2021 and April 20, 2021, respectively, the Company recorded goodwill of $6.1 billion. In January 2022, the Company completed the acquisition of a consulting services entity for purchase consideration of $41.8 million, primarily for the purpose of expanding engineering resources to address customer design opportunities, of which $25.5 million was allocated to goodwill. During fiscal 2023, the Company completed acquisitions of several companies for total purchase consideration of $103.2 million, of which $73.6 million was allocated to goodwill. The purpose of the acquisitions was to expand engineering resources staff to address customer design opportunities, access additional intellectual property and support expansion of the Company’s networking solutions. The carrying value of total goodwill as of February 3, 2024 and January 28, 2023 was $11.6 billion. See “Note 7 – Business Combinations” for discussion of acquisitions and changes to the carrying value of goodwill. The Company has identified that its business operates as a single operating segment and as a single reporting unit for the purpose of goodwill impairment testing. The Company’s annual test for goodwill impairment as of the last day of the fourth quarter of fiscal 2024 did not result in any impairment charge. There was no activity from acquisitions or divestitures recorded to goodwill in fiscal 2024 and 2023 other than those described above. Acquired Intangible Assets, Net In connection with the Innovium acquisition on October 5, 2021, the Company acquired $433.0 million of intangible assets as follows (in millions, except for weighted-average useful life as of acquisition date): Preliminary Estimated Asset Fair Value Weighted-Average Useful Life (Years) Developed technology $ 274.0 8.0 Customer contracts and related relationships 66.0 8.0 IPR&D 93.0 n/a $ 433.0 In connection with the Inphi acquisition on April 20, 2021, the Company acquired $4.4 billion of intangible assets as follows (in millions, except for weighted-average useful life as of acquisition date): Preliminary Estimated Asset Fair Value Weighted-Average Useful Life (Years) Developed technology $ 2,010.0 6.0 Customer contracts and related relationships 1,470.0 6.0 Order backlog 70.0 0.8 Trade name 50.0 5.0 IPR&D 820.0 n/a $ 4,420.0 As of February 3, 2024 and January 28, 2023, net carrying amounts excluding fully amortized intangible assets are as follows (in millions, except for weighted-average remaining amortization period): February 3, 2024 Gross Carrying Accumulated Net Carrying Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 4,989.0 $ (2,613.5) $ 2,375.5 3.8 Customer contracts and related relationships 2,179.0 (1,191.5) 987.5 3.3 Trade names 50.0 (27.9) 22.1 2.2 Total acquired amortizable intangible assets 7,218.0 (3,832.9) 3,385.1 3.6 IPR&D 619.0 — 619.0 n/a Total acquired intangible assets $ 7,837.0 $ (3,832.9) $ 4,004.1 January 28, 2023 Gross Carrying Accumulated Net Carrying Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 5,078.0 $ (2,014.5) $ 3,063.5 4.7 Customer contracts and related relationships 2,179.0 (853.2) 1,325.8 4.2 Trade names 66.0 (32.3) 33.7 3.1 Total acquired amortizable intangible assets 7,323.0 (2,900.0) 4,423.0 4.5 IPR&D 679.0 — 679.0 n/a Total acquired intangible assets $ 8,002.0 $ (2,900.0) $ 5,102.0 The intangible assets are amortized on a straight-line basis over the estimated useful lives, except for certain Cavium customer contracts and related relationships, which are amortized using an accelerated method of amortization over the expected customer lives, which more closely align with the pattern of realization of economic benefits expected to be obtained. The IPR&D will be accounted for as an indefinite-lived intangible asset and will not be amortized until the underlying projects reach technological feasibility and commercial production at which point the IPR&D will be amortized over the estimated useful life. Useful lives for these IPR&D projects are expected to range between 5 to 10 years. In the event the IPR&D is abandoned, the related assets will be written off. Amortization for acquired intangible assets was $1.1 billion, $1.1 billion and $979.4 million during the years ended February 3, 2024, January 28, 2023 and January 29, 2022, respectively. The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of February 3, 2024 (in millions): Fiscal Year Amount 2025 $ 1,052.4 2026 997.5 2027 829.9 2028 273.2 2029 107.1 Thereafter 125.0 $ 3,385.1

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Feb. 03, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is an exit price representing the amount that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 — Observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2 — Other inputs that are directly or indirectly observable in the marketplace. Level 3 — Unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company’s Level 1 assets include marketable equity investments that are classified as other non-current assets and which are valued primarily using quoted market prices. The Company’s Level 2 assets include time deposits, as the market inputs used to value these instruments consist of market yield. In addition, forward contracts and the severance pay fund are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments. The tables below set forth, by level, the Company’s assets that are measured at fair value on a recurring basis. The tables do not include assets that are measured at historical cost or any basis other than fair value (in millions): Fair Value Measurements at February 3, 2024 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits — 2.6 — 2.6 Prepaid expenses and other current assets: Foreign currency forward contracts — 1.2 — 1.2 Other non-current assets: Marketable equity investments 9.3 — — 9.3 Severance pay fund — 0.5 — 0.5 Total assets $ 9.3 $ 4.3 $ — $ 13.6 The carrying value of investments in non-marketable equity securities recorded to fair value on a non-recurring basis is adjusted for observable transactions for identical or similar investments of the same issuer or for impairment. These securities relate to equity investments in privately-held companies. These items measured at fair value on a non-recurring basis are classified as Level 3 in the fair value hierarchy because the value is estimated based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs such as volatility, rights and obligations of the securities held. As of February 3, 2024 and January 28, 2023, non-marketable equity investments had a carrying value of $45.8 million and $36.1 million, respectively, and are included in other non-current assets in the Company’s consolidated balance sheets. Fair Value Measurements at January 28, 2023 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits $ — $ 150.7 $ — $ 150.7 Other non-current assets: Marketable equity investments 3.2 — — 3.2 Severance pay fund — 0.7 — 0.7 Total assets $ 3.2 $ 151.4 $ — $ 154.6 There were no transfers of assets between levels in either fiscal 2024 or 2023. Fair Value of Debt The Company classified the 2026 Term Loan, 2026 Senior Notes, 2028 Senior Notes, 2029 Senior Notes, 2031 Senior Notes, and 2033 Senior Notes as Level 2 in the fair value measurement hierarchy. The carrying value of the 2026 Term Loan approximate its fair value as the 2026 Term Loan is carried at a market observable interest rate that resets periodically. The estimated aggregate fair value of the unsecured senior notes was $3.3 billion at February 3, 2024 and $2.7 billion at January 28, 2023, and were classified as Level 2 as there are quoted prices from less active markets for the notes. See “Note 4 – Debt” for additional information.

Restructuring

Restructuring	12 Months Ended
Restructuring	Feb. 03, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The following table provides a summary of restructuring related charges as presented in the consolidated statements of operations (in millions): Year Ended February 3, January 28, January 29, Cost of goods sold $ — $ — $ (0.8) Restructuring related charges 131.1 21.6 32.4 $ 131.1 $ 21.6 $ 31.6 The following table presents details related to the restructuring related charges as presented in the consolidated statements of operations (in millions): Year Ended February 3, January 28, January 29, Employee severance $ 93.9 $ 15.5 $ 24.1 Impairment and write-off of assets Purchased IP licenses 28.6 — — Other 8.6 6.1 7.5 $ 131.1 $ 21.6 $ 31.6 Fiscal 2024. The Company recorded $131.1 million of restructuring related charges during its evaluation of its existing operations to increase operational efficiency, decrease costs and increase profitability. A restructuring plan was initiated during the first quarter of fiscal 2024 (the “Fiscal 2024 Plan”) to streamline the organization and optimize resources. Restructuring charges are mainly comprised of severance and other one-time termination benefits, impairment and write-off of purchased IP licenses, and other costs. The charges include $93.9 million related to the Fiscal 2024 Plan primarily from severance costs. The Company expects these restructuring actions to be substantially completed by the end of fiscal 2025. Fiscal 2023. The Company recorded $21.6 million of restructuring related charges during its evaluation of its existing operations to increase operational efficiency, decrease costs and increase profitability. A restructuring plan was initiated during the first quarter of fiscal 2023 (the “Fiscal 2023 Plan”) in order to realign the organization and enable further investment in key priority areas. Restructuring charges are mainly comprised of severance and other one-time termination benefits, facility closures where sites may be redundant within the same region or no longer suitably sized for the local employee base, and other costs. The charges include $15.5 million related to the Fiscal 2023 Plan primarily from severance costs. Fiscal 2022. The Company recorded $31.6 million of restructuring related charges during its evaluation of its existing operations to increase operational efficiency, decrease costs and increase profitability. A restructuring plan was initiated during the first quarter of fiscal 2022 (the “Fiscal 2022 Plan”) in order to realign the organization and enable further investment in key priority areas as part of the integration of the acquisitions as described in “Note 7 - Business Combinations.” Restructuring charges are mainly comprised of severance and other one-time termination benefits, facility closures where sites may be redundant within the same region or no longer suitably sized for the local employee base, and other costs. The charges include $24.1 million related to the Fiscal 2022 Plan primarily from severance costs. The following table sets forth a reconciliation of the beginning and ending restructuring liability balances by each major type of costs associated with the restructuring charges (in millions): July 2018 November 2019 Restructuring July 2020 Fiscal 2022 Restructuring Fiscal 2023 Restructuring Fiscal 2024 Restructuring Employee Severance Other Employee Severance Other Employee Severance Other Employee Severance Other Employee Severance Other Employee Severance Other Total Balance at January 29, 2022 $ 0.4 $ 1.1 $ 0.2 $ — $ 0.3 $ 1.5 $ 2.1 $ — $ — $ — $ — $ — $ 5.6 Charges — 5.5 — — — 0.3 — — 15.4 0.4 — — 21.6 Net Cash payments (0.4) — (0.2) — (0.3) (1.4) (2.1) — (11.8) (0.4) — — (16.6) Non-cash items — (5.6) — — — — — — — — — — (5.6) Balance at January 28, 2023 — 1.0 — — — 0.4 — — 3.6 — — — 5.0 Charges — 0.3 — — — — — — — — 93.9 36.9 131.1 Net Cash payments — 2.4 — — — (0.4) — — (3.6) — (78.4) (24.5) (104.5) Non-cash items — (2.9) — — — — — — — — — (11.7) (14.6) Balance at February 3, 2024 — 0.8 — — — — — — — — 15.5 0.7 17.0 Less: non-current portion — 0.6 — — — — — — — — — 0.3 0.9 Current portion $ — $ 0.2 $ — $ — $ — $ — $ — $ — $ — $ — $ 15.5 $ 0.4 $ 16.1 The current and non-current portions of the restructuring liability at February 3, 2024 of $16.1 million and $0.9 million are included as a component of accrued liabilities and other non-current liabilities, respectively, in the accompanying consolidated balance sheets.

Stockholders_ Equity

Stockholders’ Equity	12 Months Ended
Stockholders’ Equity	Feb. 03, 2024
Equity [Abstract]
Stockholders’ Equity	Stockholders’ Equity Preferred and Common Stock Under the terms of the Company’s Certificate of Incorporation, the Board of Directors may determine the rights, preferences, and terms of the Company’s authorized but unissued shares of preferred stock. As of February 3, 2024, the Company is authorized to issue 8.0 million shares of $0.002 par value preferred stock and 1.3 billion shares of $0.002 par value common stock. As of February 3, 2024 and January 28, 2023, no shares of preferred stock were outstanding. Restricted Stock In connection with an acquisition in fiscal 2023, the Company granted 0.4 million shares of unregistered restricted stock, which is subject to certain vesting conditions. Restricted Stock Unit Withholdings For the years ended February 3, 2024, January 28, 2023, and January 29, 2022, the Company withheld approximately 4.3 million, 4.2 million and 4.8 million shares, or $223.7 million, $227.6 million, and $299.9 million of common stock, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock. Cash Dividends on Shares of Common Stock During fiscal 2024, the Company declared and paid cash dividends of $0.24 per common stock, or $206.8 million, on the Company’s outstanding common stock. During fiscal 2023, the Company declared and paid cash dividends of $0.24 per common stock, or $204.4 million, on the Company’s outstanding common stock. During fiscal 2022, the Company declared and paid cash dividends of $0.24 per common stock, or $191.0 million, on the Company’s outstanding common stock. Any future dividends will be subject to the approval of the Company’s Board of Directors. Stock Repurchase Program On November 17, 2016, the Company announced that its Board of Directors authorized a $1.0 billion stock repurchase plan with no fixed expiration. The stock repurchase program replaced in its entirety the prior $3.3 billion stock repurchase program. On October 16, 2018, the Company announced that its Board of Directors authorized a $700.0 million addition to the balance of its existing stock repurchase plan. The Company intends to effect stock repurchases in accordance with the conditions of Rule 10b-18 under the Exchange Act, but may also make repurchases in the open market outside of Rule 10b-18 or in privately negotiated transactions. The stock repurchase program is subject to market conditions, legal rules and regulations, and other factors, and does not obligate the Company to repurchase any dollar amount or number of shares of its common stock and the repurchase program may be extended, modified, suspended or discontinued at any time. Subsequent to fiscal year end, in March 2024, the Company’s Board of Directors increased the repurchase program mentioned above and authorized an additional $3.0 billion to that repurchase program. The Company resumed its stock repurchase program in the first quarter of fiscal 2023, which had been temporarily suspended in fiscal 2021 to preserve cash during the COVID-19 pandemic. The Company repurchased 2.5 million of its common stock for $150.0 million, including 0.8 million shares of its common stock repurchased for $50.0 million pursuant to a 10b5-1 trading plan during fiscal 2024, and 2.3 million shares of its common stock for $115.0 million, including 0.9 million shares of its common stock repurchased for $50.0 million pursuant to a 10b5-1 trading plan during fiscal 2023. There were no stock repurchases during fiscal 2022. The repurchased shares of stock were retired immediately after the repurchases were completed. The Company records all repurchases, as well as investment purchases and sales, based on their trade date. As of February 3, 2024, a total of 312.9 million shares of stock have been repurchased to date under the Company’s stock repurchase program for a total $4.5 billion in cash and there was $299.5 million remaining available for future stock repurchases. A summary of the stock repurchase activity under the stock repurchase program, reported based on the trade date, is summarized as follows (in millions, except per share amounts): Shares Weighted- Amount Cumulative balance at January 30, 2021 308.1 $ 13.86 $ 4,270.0 Repurchase of common stock under the stock repurchase program — $ — $ — Cumulative balance at January 29, 2022 308.1 $ 13.86 $ 4,270.0 Repurchase of common stock under the stock repurchase program 2.3 $ 49.93 $ 115.0 Cumulative balance at January 28, 2023 310.4 $ 14.12 $ 4,385.0 Repurchase of common stock under the stock repurchase program 2.5 $ 61.51 $ 150.0 Cumulative balance at February 3, 2024 312.9 $ 14.49 $ 4,535.0

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Feb. 03, 2024
Share-Based Payment Arrangement [Abstract]
Employee Benefit Plans	Employee Benefit Plans Employee Stock Compensation Plans 1995 Stock Option Plan In April 1995, the Company adopted the 1995 Stock Option Plan (the “Option Plan”). The Option Plan, as amended from time to time, had 383.4 million shares of common stock reserved for issuance thereunder as of February 3, 2024. As of February 3, 2024, approximately 50.6 million shares remained available for future grants under the Option Plan. Under the Option Plan, the Company may issue restricted stock unit (“RSU”) awards, performance-based restricted stock unit (“PRSU”) awards, stock options, and other types of stock awards, all of which may be subject to vesting over a specified service term, generally three RSUs granted under the Option Plan include time-based RSUs and PRSUs. Time-based RSUs generally vest over a three four three Options granted under the Option Plan generally have a term of 10 years and must be issued at prices equal to the fair market value of the stock on the date of grant. Options generally vest over a three In December 2017, the Company’s Executive Compensation Committee approved a deferred stock program, whereby executives of the Company have the option, beginning in 2018, to defer the settlement of time-based and performance-based restricted stock units granted under the Option Plan to a future date. In June 2021, the Company extended the stock deferral program to members of the Board of Directors. A deferral election is irrevocable after the annual submission deadline. The shares of common stock underlying the deferred grants will be distributed at the earliest of the employee’s specified future settlement date or upon separation from service, a change in control, or death or disability. Outside Director Equity Compensation Policy In September 2016, the Company’s Board of Directors approved an Outside Director Equity Compensation Policy that governs the grant of equity awards to non-employee directors under the Option Plan. Under the current Outside Director Compensation Policy, each outside director, upon appointment to fill a vacancy on the board or in connection with election at an annual meeting of stockholders, will be granted an RSU award under the Option Plan. The RSU award vests 100% on the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the date of grant. Assumed Employee Stock Compensation Plans In connection with past acquisitions, the Company assumed equity incentive plans of certain acquired companies (collectively “the Assumed Plans”), and the equity awards assumed in connection with each acquisition were granted from their respective assumed plans. The assumed equity awards will be settled in shares of the Company’s common stock and will retain the terms and conditions under which they were originally granted. No additional equity awards will be granted under the Assumed Plans. In connection with the Inphi acquisition, the awards under the Assumed Plans were measured at the acquisition date based on the estimated fair value of $589.7 million. A portion of that fair value, $161.7 million, which represented the pre-acquisition service provided by employees to Inphi, was included in the total consideration transferred as part of the acquisition. As of the acquisition date, the remaining portion of the fair value of those awards was $428.0 million, representing post-acquisition stock-based compensation expense that will be recognized as these employees provide service over the remaining vesting periods. In connection with Innovium acquisition, the awards under the Assumed Plans were measured at the acquisition date based on the estimated fair value of $80.9 million. A portion of that fair value, $39.8 million, which represented the pre-acquisition service provided by employees to Innovium, was included in the total consideration transferred as part of the acquisition. As of the acquisition date, the remaining portion of the fair value of those awards was $41.1 million, representing post-acquisition stock-based compensation expense that will be recognized as these employees provide service over the remaining vesting periods. Employee Stock Purchase Plan Under the 2000 Employee Stock Purchase Plan, as amended and restated on April 2, 2021 (the “ESPP”), participants purchase the Company’s stock using payroll deductions, which may not exceed 15% of their total cash compensation. The ESPP provides for a 24-month offering period, with four six-month purchase periods. Participants are granted the right to purchase common stock at a price per share that is 85% of the lesser of the fair market value of the common stock at (i) the participant’s enrollment date into the two-year offering period or (ii) the end of each six-month purchase period within the offering period. Under the ESPP, a total of 2.4 million shares were issued in fiscal 2024 at a weighted-average price of $35.57 per share, a total of 2.3 million shares were issued in fiscal 2023 at a weighted-average price of $37.52 per share, and a total of 2.4 million shares were issued in fiscal 2022 at a weighted-average price of $31.96 per share. As of February 3, 2024, there was $42.7 million of unamortized compensation cost related to the ESPP. As of February 3, 2024, approximately 41.5 million shares remained available for future issuance under the ESPP. Summary of Stock-Based Compensation Expense The following table summarizes stock-based compensation expense (in millions): Year Ended February 3, January 28, January 29, Cost of goods sold $ 49.1 $ 43.3 $ 31.1 Research and development 411.1 372.4 273.2 Selling, general and administrative 149.6 136.7 173.2 Total stock-based compensation $ 609.8 $ 552.4 $ 477.5 The income tax benefit recognized from stock-based compensation expense was $95.3 million, $89.9 million and $71.8 million for the year ended February 3, 2024, January 28, 2023 and January 29, 2022, respectively. Stock-based compensation capitalized in inventory was $18.2 million at February 3, 2024, $20.3 million at January 28, 2023 and $18.4 million at January 29, 2022. The income tax benefit related to equity awards vested or exercised was $24.3 million $21.7 million and $63.0 million during the year ended February 3, 2024, January 28, 2023 and January 29, 2022, respectively. Restricted Stock and Stock Unit Awards A summary of restricted stock and stock unit activity for time-based and performance-based awards is as follows (in millions, except per share amounts): Time-Based Performance-Based Number of Weighted-Average Number of Weighted-Average Unvested Balance at January 28, 2023 15.5 $ 51.71 3.1 $ 47.51 Granted 14.2 $ 41.50 3.3 $ 37.78 Vested (11.1) $ 47.19 (1.6) $ 36.16 Canceled/Forfeited (2.4) $ 48.76 (0.2) $ 50.76 Unvested Balance at February 3, 2024 16.2 $ 46.36 4.6 $ 44.17 The aggregate intrinsic value of RSUs vested and expected to vest as of February 3, 2024 was $1.1 billion. The weighted-average grant date fair value for RSUs granted was $41.50, $55.73 and $55.47 for the year ended February 3, 2024, January 28, 2023 and January 29, 2022, respectively. The total fair value of RSUs vested during the year ended February 3, 2024, January 28, 2023 and January 29, 2022 was $523.7 million, $519.6 million and $313.3 million, respectively. As of February 3, 2024, unamortized compensation expense related to RSUs was $688.6 million, which is expected to be recognized over a weighted-average period of 2.0 years. The aggregate intrinsic value of PRSUs vested and expected to vest as of February 3, 2024 was $309.1 million. The weighted-average grant date fair value for PRSUs granted was $37.78, $45.40 and $52.97 for the year ended February 3, 2024, January 28, 2023 and January 29, 2022, respectively. The total fair value of PRSUs vested during the year ended February 3, 2024, January 28, 2023 and January 29, 2022 was $56.0 million, $38.5 million and $42.5 million, respectively. As of February 3, 2024, unamortized compensation expense related to PRSUs was $127.8 million, which is expected to be recognized over a weighted-average period of 2.0 years. Stock Option Awards Option Plan and Stock Award Activity Stock option activity under the Company’s Option Plan and other stock incentive plans mentioned above (excluding the ESPP) is included in the following table (in millions, except for per share amounts and weighted-average contractual term): Number of Weighted- Weighted- Average Contractual Term (Years) Aggregate Intrinsic Value Balance at January 28, 2023 1.9 $ 12.80 1.8 $ 60.2 Granted — $ — Exercised (1.2) $ 12.06 Canceled/Forfeited — $ — Balance at February 3, 2024 0.7 $ 14.00 1.8 $ 38.6 Exercisable at February 3, 2024 0.7 $ 14.00 1.8 $ 38.6 Vested or expected to vest at February 3, 2024 0.7 $ 14.00 1.8 $ 38.6 The aggregate intrinsic value of stock options exercised during the year ended February 3, 2024, January 28, 2023 and January 29, 2022 was $43.5 million, $21.5 million and $43.3 million respectively. Valuation of Employee Stock-Based Awards The expected volatility for awards granted during fiscal 2024, 2023 and 2022 was based on historical stock price volatility. The expected dividend yield is calculated by dividing the current annualized dividend by the closing stock price on the date of grant of the option or award. There were no options granted in fiscal 2024, 2023 and 2022 except for the ones the Company assumed from the Inphi and Innovium acquisitions. The following weighted-average assumptions were used for each respective period to calculate the fair value of common stock to be issued under the ESPP on the date of grant using the Black-Scholes option pricing model: Year Ended February 3, January 28, January 29, Employee Stock Purchase Plan: Estimated fair value $ 21.44 $ 17.42 $ 24.14 Expected volatility 55 % 58 % 46 % Expected term (in years) 1.3 1.3 1.3 Risk-free interest rate 5.0 % 4.1 % 0.2 % Expected dividend yield 0.4 % 0.6 % 0.4 % The following weighted-average assumptions were used for each respective period to calculate the fair value of common stock to be issued under PRSU awards on the date of grant using the Monte Carlo pricing model: Year Ended February 3, January 28, January 29, PRSUs: Expected term (in years) 3.5 3.0 3.0 Expected volatility 50 % 51 % 44 % Average correlation coefficient of peer companies 0.7 0.7 0.6 Risk-free interest rate 3.7 % 3.3 % 0.3 % Expected dividend yield 0.6 % 0.5 % 0.5 % The correlation coefficients are calculated based upon the price data used to calculate the historical volatilities and is used to model the way in which each entity tends to move in relation to its peers. Employee 401(k) Plans The Company sponsors a 401(k) savings and investment plan that allows eligible U.S. employees to participate by making pre-tax, Roth and after-tax contributions to the 401(k) plan ranging from 1% to 75% of eligible earnings subject to a required annual limit. The Company currently matches 100% of 5% of eligible salary to a $5,000 maximum contribution effective from January 1, 2023. The Company made matching contributions to employees of $15.5 million in fiscal 2024, $15.9 million in fiscal 2023 and $14.5 million in fiscal 2022. As of February 3, 2024, the 401(k) plan offers a variety of investment alternatives, representing different asset classes. Employees may not invest in the Company’s common stock through the 401(k) plan. The Company also has voluntary defined contribution plans in various non-U.S. locations. In connection with these plans, the Company made contributions on behalf of employees totaling $11.4 million, $11.3 million and $11.0 million during fiscal 2024, 2023 and 2022, respectively.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Feb. 03, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The U.S. and non-U.S. components of income (loss) from continuing operations before income taxes consist of the following (in millions): Year Ended February 3, January 28, January 29, U.S. operations $ (383.3) $ (452.7) $ (621.2) Non-U.S. operations (375.4) 537.8 137.7 Income (loss) before income taxes $ (758.7) $ 85.1 $ (483.5) The provision (benefit) for income taxes consists of the following (in millions): Year Ended February 3, January 28, January 29, Current income tax provision (benefit): Federal $ (1.0) $ 57.8 $ — State (2.1) 3.3 0.7 Foreign 27.0 137.1 30.7 Total current income tax provision 23.9 198.2 31.4 Deferred income tax provision (benefit): Federal 186.9 (118.8) (83.4) State 4.7 (17.5) (9.2) Foreign (40.8) 186.7 (1.3) Total deferred income tax provision (benefit) 150.8 50.4 (93.9) Total provision (benefit) for income taxes $ 174.7 $ 248.6 $ (62.5) The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income (loss) before income taxes as follows (in millions): Year Ended February 3, January 28, January 29, Provision (benefit) at U.S. statutory rate $ (159.3) $ 17.9 $ (101.5) State taxes, net of federal benefit 2.5 (13.8) (8.1) Difference in U.S. and non-U.S. tax rates 69.5 (16.0) 1.7 Foreign income inclusion in U.S. 220.0 194.4 54.1 Change in federal valuation allowance 92.4 (73.8) 62.7 Federal research and development credits (88.0) (96.1) (60.7) Stock-based compensation (0.5) (2.0) (70.9) Non-deductible compensation 15.8 15.1 47.9 Intellectual property transaction 15.3 — — Uncertain tax positions 1.0 (16.5) (1.5) Federal tax attribute expiration — 5.8 — Singapore incentive rate extension — 213.6 — Transaction costs — 0.4 5.7 Israel income tax recapture — 18.3 — Other 6.0 1.3 8.1 Total provision (benefit) for income taxes $ 174.7 $ 248.6 $ (62.5) The income tax expense for fiscal 2024 differs from the U.S. federal statutory rate of 21% as a result of foreign income inclusions in the U.S., a portion of the Company’s earnings or losses being taxed or benefited at rates lower than the U.S. statutory rate, research and development credit generation, and disallowed deductions related to non-deductible compensation. Further, during fiscal 2024, guidance was issued by the U.S. Internal Revenue Service in connection with the capitalization of research and development expenditures. As a result of this guidance, certain costs are currently deductible rather than capitalizable, which resulted in a reduction to the Company’s income tax payable and an increase in its deferred tax assets for which the Company maintains a full valuation allowance. The income tax expense for fiscal 2023 differs from the U.S. federal statutory rate of 21% primarily due to the remeasurement of Singapore deferred taxes upon extension of the Company’s tax incentive in Singapore, tax benefits attributable to a net reduction of unrecognized tax benefits as a result of settled income tax audits in combination with the lapsing of statute of limitations, offset by foreign income inclusions in the U.S., and a tax expense related to the recapture of certain Israel corporate income taxes. The income tax expense for fiscal 2023 is also impacted by a substantial portion of the Company’s earnings, or in some cases, losses being taxed or benefited at rates lower than the U.S. statutory rate, stock-based compensation tax benefits, and disallowed deductions related to non-deductible compensation. The income tax benefit for fiscal 2022 differs from the U.S. federal statutory rate of 21% primarily due to tax benefits of stock-based compensation, offset by foreign income inclusions in the U.S. and non-deductible compensation. Deferred tax assets and liabilities consist of the following (in millions): February 3, January 28, Deferred tax assets: Net operating losses $ 107.9 $ 124.9 Federal and California income tax credits 1,056.6 917.4 Intangible assets 580.0 684.7 Lease liabilities 44.9 49.7 Capitalized R&D — 253.8 Other 86.4 65.2 Gross deferred tax assets 1,875.8 2,095.7 Valuation allowance (1,099.0) (961.7) Total deferred tax assets 776.8 1,134.0 Deferred tax liabilities: Intangible assets (421.4) (648.5) Fixed assets (39.0) (13.6) Unremitted earnings of non-U.S. subsidiaries (26.7) (24.7) Right of use assets (36.5) (45.5) Total deferred tax liabilities (523.6) (732.3) Net deferred tax assets $ 253.2 $ 401.7 The deferred taxes reflected above for fiscal 2024 include the impact of the IRS guidance issued in December 2023 related to R&D capitalization. The fiscal 2023 deferred tax amount related to capitalized R&D of $253.8 million was reversed in full and R&D tax credits of $111.2 million were reinstated, along with associated valuation allowances of $111.2 million. The deferred tax assets and liabilities based on tax jurisdictions are presented on the Company’s consolidated balance sheets as follows (in millions): February 3, January 28, Non-current deferred tax assets $ 311.9 $ 465.9 Non-current deferred tax liabilities (58.7) (64.2) Net deferred tax assets $ 253.2 $ 401.7 The ultimate realization of deferred tax assets depends upon the generation of future taxable income during the periods in which those assets become deductible or creditable. The Company evaluates the recoverability of its deferred tax assets, weighing all positive and negative evidence, and provides or maintains a valuation allowance for these assets if it is more likely than not that some, or all, of the deferred tax assets will not be realized. If negative evidence exists, sufficient positive evidence is necessary to support a conclusion that a valuation allowance is not needed. The Company considers all available evidence such as its earnings history including the existence of cumulative income or losses, reversals of taxable temporary differences, projected future taxable income, and tax planning strategies. In the U.S., and in certain foreign jurisdictions, the Company has deferred tax assets for which partial valuation allowances have been established. After weighing all available evidence, particularly the earnings history and forecasts of future taxable income in each respective jurisdiction, as well as its history of tax credits expiring unused, the Company determined that negative evidence outweighed positive evidence with respect to the ability to realize federal, state, and foreign research and development and other tax credits, as well as certain other foreign deferred tax assets. The valuation allowance increased by $137.3 million from fiscal 2023, primarily as a result of re-established R&D credits based on IRS guidance on R&D capitalization issued in December 2023. The Company maintains a valuation allowance on its U.S. R&D credits based on the factors listed above as well as forecasted R&D credit utilization and expected R&D credit generation in future years. In future periods, it is possible that significant positive or negative evidence could arise that results in a change in the Company’s judgment with respect to the need for a valuation allowance, which could result in a tax benefit, or adversely affect the Company’s income tax provision, in the period of such change in judgment. As of February 3, 2024, the Company had net operating loss carryforwards available to offset future taxable income of approximately $629.7 million, $818.3 million, $243.9 million and $2.1 million for U.S. federal, state of California, other U.S. states, and foreign purposes, respectively. If not utilized, the federal loss carryforwards begin to expire in fiscal 2032, and the California carryforwards begin to expire in fiscal 2027. The majority of the Company’s foreign losses carry forward indefinitely. The Company also had federal research and other tax credit carryforwards of approximately $621.4 million, which begin to expire in fiscal 2025. As of February 3, 2024, the Company also had California research tax credit carryforwards of approximately $698.7 million, which can be carried forward indefinitely. In addition, the Company has research and other tax credit carryforwards of approximately $43.1 million in other U.S. states, which begin to expire in fiscal 2025. The Company also has research and other tax credit carryforwards of approximately $13.8 million in foreign jurisdictions, which begin to expire in fiscal 2027. The Company’s net operating loss and tax credit carryforwards may be subject to audit and adjusted for changes or modification in tax laws, other authoritative interpretations, or other facts and circumstances. Utilization of the Company’s U.S. federal and state net operating loss and credit carryforwards may be subject to annual limitations due to ownership change provisions of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. Future changes in the Company’s stock ownership, some of which are generally outside of the Company’s control, could result in an ownership change under Section 382 and Section 383 and result in a limitation on U.S. tax attributes. The Company has determined that no significant limitation would be placed on the utilization of its net operating loss and tax credit carry-forwards due to prior ownership changes. The following table reflects changes in the unrecognized tax benefits (in millions): Year Ended February 3, January 28, January 29, Unrecognized tax benefits as of the beginning of the period $ 317.5 $ 334.0 $ 242.2 Increases related to acquired tax positions — — 94.6 Increases related to prior year tax positions — 2.0 1.5 Decreases related to prior year tax positions (0.8) (16.4) — Increases related to current year tax positions 163.1 6.8 7.7 Settlements (1.0) — (5.9) Lapse in the statute of limitations (1.8) (8.6) (5.6) Foreign exchange gain (0.5) (0.3) (0.5) Gross amounts of unrecognized tax benefits as of the end of the period $ 476.5 $ 317.5 $ 334.0 The Company has recorded $476.5 million of gross unrecognized tax benefits as of February 3, 2024, of which $196.0 million would affect the Company’s effective income tax rate if recognized. $239.9 million of the Company’s gross unrecognized tax benefits as of February 3, 2024 relate to income tax positions which, if recognized, would increase deferred tax assets that are subject to valuation allowances. The total amount of interest and penalties accrued was approximately $3.8 million, $3.2 million, and $3.9 million as of February 3, 2024, January 28, 2023, and January 29, 2022, respectively. The consolidated statements of operations for fiscal 2024, 2023, and 2022 included accruals of $1.3 million, $1.6 million, and $0.6 million, respectively, of interest and penalties related to unrecognized tax benefits. The Company’s major tax jurisdictions are the United States, the states of California and Massachusetts, Singapore, China, India, Germany, and Israel. The Company is subject to income tax audits by the respective tax authorities in all of the jurisdictions in which it operates. The examination of tax liabilities in each of these jurisdictions requires the interpretation and application of complex and sometimes uncertain tax laws and regulations. As of February 3, 2024, the Company is subject to examination in material jurisdictions including China, India, Israel, Singapore, Germany, and the United States for fiscal 2003 through 2024. During the next 12 months, it is reasonably possible that the amount of unrecognized tax benefits could increase or decrease significantly due to changes in tax law in various jurisdictions, new tax audits and changes in the U.S. dollar as compared to foreign currencies within the next 12 months. Excluding these factors, the Company does not expect a material decrease to its uncertain tax positions as a result of the lapse of the statutes of limitations in various jurisdictions during the next 12 months. The Singapore Economic Development Board (“EDB”) initially granted a 10-year Pioneer Status in July 1999 to the Company’s Singapore subsidiary. After the conclusion of the initial Pioneer status, the EDB granted an incentive known as the Development and Expansion Incentive (“DEI”) and extended the Pioneer status over multiple years. During the first quarter of fiscal 2023, the EDB agreed to extend the Company’s DEI by five years, through June 30, 2029. To retain the current DEI tax benefits through June 2029 in Singapore, the Company must meet certain operating conditions, headcount and investment requirements, as well as maintain certain activities in Singapore. In fiscal 2024 and 2023, no Singapore tax incentive net tax benefits were recorded. In fiscal 2022, tax savings associated with this tax incentive were approximately $11.8 million, which if paid would impact the Company’s earnings per share by $0.01 per share. Marvell Israel (M.I.S.L) Ltd., is entitled to certain tax benefits under the Israeli Encouragement of Investments Law (“Encouragement Law”) Special Technology Enterprise Regime, which includes reduced corporate income tax rates, subject to various operating requirements and other conditions. In fiscal 2024, tax savings associated with this program were approximately $8.7 million, which if paid, would impact the Company’s earnings per share by $0.01 per share. In fiscal 2023, tax savings associated with this program were approximately $11.2 million, which if paid, would impact the Company’s earnings per share by $0.01 per share. There was no tax benefit in fiscal 2022. The Company’s principal source of liquidity as of February 3, 2024 consisted of approximately $950.8 million of cash and cash equivalents, of which approximately $744.1 million was held by subsidiaries outside of the United States. In addition, the Company has an undrawn revolving credit facility of $1.0 billion. The Company has not recognized a deferred tax liability on $154.0 million of assets held by subsidiaries as such amounts are deemed to be indefinitely reinvested. The Company manages its worldwide cash requirements by, among other things, reviewing available funds held by its foreign subsidiaries and the cost effectiveness by which those funds can be accessed in the United States.

Net Loss Per Share

Net Loss Per Share	12 Months Ended
Net Loss Per Share	Feb. 03, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The Company reports both basic net loss per share, which is based on the weighted-average number of common stock outstanding during the period, and diluted net loss per share, which is based on the weighted-average number of common stock outstanding and potentially dilutive shares outstanding during the period. The computations of basic and diluted net loss per share are presented in the following table (in millions, except per share amounts): Year Ended February 3, January 28, January 29, Numerator: Net loss $ (933.4) $ (163.5) $ (421.0) Denominator: Weighted-average shares — basic 861.3 851.4 796.9 Effect of dilutive securities: Stock-based awards — — — Weighted-average shares — diluted 861.3 851.4 796.9 Net loss per share: Basic $ (1.08) $ (0.19) $ (0.53) Diluted $ (1.08) $ (0.19) $ (0.53) Potential dilutive securities include dilutive common stock from stock-based awards attributable to the assumed exercise of stock options, restricted stock units and employee stock purchase plan shares using the treasury stock method. Potential dilutive securities include dilutive common stock from stock-based awards attributable to the shares that could be issued upon conversion of the Company’s convertible debt using the if-converted method. Under the treasury stock method and if-converted method, potential common stock outstanding are not included in the computation of diluted net income per share, if their effect is anti-dilutive. Anti-dilutive potential shares are presented in the following table (in millions): Year Ended February 3, January 28, January 29, Weighted-average shares outstanding: Stock-based awards 10.9 21.0 16.1 Convertible debt — — 0.5 Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for all periods reported above because either their exercise price exceeded the average market price during the period or the stock-based awards were determined to be anti-dilutive based on applying the treasury stock method. Anti-dilutive potential shares from convertible debt are excluded from the calculation of diluted earnings per share for all periods reported above because the shares that would be issued upon conversion of the Company’s convertible debt were determined to be anti-dilutive based on applying the if-converted method. Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for the years ended February 3, 2024, January 28, 2023, and January 29, 2022 due to the net losses reported in those periods.

Segment and Geographic Informat

Segment and Geographic Information	12 Months Ended
Segment and Geographic Information	Feb. 03, 2024
Segment Reporting [Abstract]
Segment and Geographic Information	Segment and Geographic Information The Company operates in one reportable segment — the design, development and sale of integrated circuits. The chief executive officer was identified as the chief operating decision maker (“CODM”) and is ultimately responsible for and actively involved in the allocation of resources and the assessment of the Company’s performance. The fact that the Company operates in only one reportable segment is based on the following: • The Company uses a highly-integrated approach in developing its products in that discrete technologies developed by the Company are frequently integrated across many of its products. Substantially all of the Company’s integrated circuits are manufactured under similar manufacturing processes. • The Company’s organizational structure is based along functional lines. Each of the functional department heads reports directly to the CODM. Shared resources in the Company also report directly to the CODM or to a direct report of the CODM. • The assessments of performance across the Company, including assessment of the Company’s incentive compensation plan, are based largely on operational performance and consolidated financial performance. • The decisions on allocation of resources and other operational decisions are made by the CODM based on his direct involvement with the Company’s operations and product development. The following table presents long-lived asset information based on the physical location of the assets by geographic region (in millions): February 3, January 28, Property and equipment, net: United States $ 518.6 $ 418.6 Singapore 159.7 94.5 Israel 33.0 18.2 India 20.7 15.6 China 2.3 10.9 Others 21.7 19.6 $ 756.0 $ 577.4

Supplemental Financial Informat

Supplemental Financial Information	12 Months Ended
Supplemental Financial Information	Feb. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Information	Supplemental Financial Information (in millions) Consolidated Balance Sheets February 3, January 28, Cash and cash equivalents: Cash $ 948.2 $ 760.3 Cash equivalents: Time deposits 2.6 150.7 Cash and cash equivalents $ 950.8 $ 911.0 Short-term, highly liquid investments of $2.6 million and $150.7 million as of February 3, 2024 and January 28, 2023, respectively, included in cash and cash equivalents on the accompanying consolidated balance sheets are not considered as investments because of the short-term maturity of such investments. February 3, January 28, Accounts receivable, net: Accounts receivable $ 1,123.6 $ 1,194.3 Less: Doubtful accounts (2.0) (2.1) Accounts receivable, net $ 1,121.6 $ 1,192.2 The Company sells certain of its trade accounts receivable on a non-recourse basis to a third-party financial institution pursuant to a factoring arrangement. The Company accounts for these transactions as sales of receivables and presents cash proceeds as cash provided by operating activities in the consolidated statements of cash flows. After the sale of its trade accounts receivable, the Company will collect payment from the customer and remit it to the third-party financial institution. Total trade accounts receivable sold under the factoring arrangement were $335.7 million for the year ended February 3, 2024, of which $155.9 million remained subject to servicing by the Company as of February 3, 2024. Factoring fees for the sales of receivables were recorded in other income, net and were not material. February 3, January 28, Inventories: Work-in-process $ 523.8 $ 756.3 Finished goods 340.6 312.0 Inventories $ 864.4 $ 1,068.3 February 3, January 28, Property and equipment, net: Machinery and equipment $ 1,376.2 $ 1,083.9 Land, buildings, and leasehold improvements 312.4 306.2 Computer software 116.5 114.5 Furniture and fixtures 31.7 30.9 1,836.8 1,535.5 Less: Accumulated depreciation (1,080.8) (958.1) Property and equipment, net $ 756.0 $ 577.4 The Company recorded depreciation expense of $148.2 million, $126.8 million and $113.5 million for fiscal 2024, 2023 and 2022, respectively. February 3, January 28, Other non-current assets: Prepaid ship and debit $ 547.6 $ 481.3 Technology licenses (1) 350.6 439.5 Prepayments on supply capacity reservation agreements 302.5 282.3 Operating right-of-use assets 203.6 211.3 Non-marketable equity investments 45.8 36.1 Other 56.8 58.3 Other non-current assets $ 1,506.9 $ 1,508.8 (1) Amortization of technology licenses was $177.1 million, $189.5 million and $149.5 million in fiscal 2024, 2023 and 2022, respectively. February 3, January 28, Accrued liabilities: Variable consideration estimates (1) $ 610.7 $ 572.8 Technology license obligations 105.7 119.1 Accrued legal reserve 76.5 102.0 Deferred revenue 43.2 45.2 Accrued interest payable 41.3 22.1 Lease liabilities - current portion 39.4 43.8 Accrued warranty expense 25.5 2.4 Deferred non-recurring engineering credits 21.7 20.0 Accrued income tax payable 17.8 118.4 Other 51.1 46.2 Accrued liabilities $ 1,032.9 $ 1,092.0 (1) Substantially all of the variable consideration estimate is comprised of the ship & debit accrual reserve, but also includes estimated customer returns, price discounts, price protection, rebates, and stock rotation programs. February 3, January 28, Other non-current liabilities: Technology license obligations $ 196.5 $ 267.0 Lease liabilities - non-current 196.0 201.6 Deferred tax liabilities 58.7 64.2 Non-current income taxes payable 56.6 28.5 Other 16.5 29.2 Other non-current liabilities $ 524.3 $ 590.5 Accumulated Other Comprehensive Income During the year ended January 29, 2022, there was no change in accumulated other comprehensive income. The changes in accumulated other comprehensive income, net of tax, by components for the comparative period are presented in the following table (in millions): Unrealized Gain Balance at January 29, 2022 $ — Other comprehensive income (loss) before reclassifications (0.9) Amounts reclassified from accumulated other comprehensive income (loss) 0.9 Net current-period other comprehensive income (loss), net of tax — Balance at January 28, 2023 — Other comprehensive income (loss) before reclassifications (1.5) Amounts reclassified from accumulated other comprehensive income (loss) 2.6 Net current-period other comprehensive income (loss), net of tax 1.1 Balance at February 3, 2024 $ 1.1 Consolidated Statements of Cash Flows Year Ended February 3, January 28, January 29, Supplemental Cash Flow Information: Cash paid for interest $ 173.7 $ 147.9 $ 91.2 Cash paid for income taxes, net $ 120.6 $ 95.9 $ 7.9 Non-Cash Investing and Financing Activities: Non-cash consideration paid and consideration unpaid for the acquisitions $ — $ 9.2 $ 7,231.8 Purchase of software and intellectual property under license obligations $ 56.2 $ 108.9 $ 325.5 Unpaid purchase of property and equipment at end of year $ 80.1 $ 63.2 $ 20.7

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	Feb. 03, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (In millions) Balance at Additions Deductions Balance at Fiscal year ended February 3, 2024 Allowance for doubtful accounts $ 2.1 $ 0.8 $ (0.9) $ 2.0 Deferred tax asset valuation allowance $ 961.7 $ 138.1 $ (0.8) $ 1,099.0 Fiscal year ended January 28, 2023 Allowance for doubtful accounts $ 3.0 $ 1.2 $ (2.1) $ 2.1 Deferred tax asset valuation allowance $ 1,003.4 $ — $ (41.7) $ 961.7 Fiscal year ended January 29, 2022 Allowance for doubtful accounts $ 2.1 $ 1.5 $ (0.6) $ 3.0 Deferred tax asset valuation allowance $ 749.5 $ 253.9 $ — $ 1,003.4

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ (933.4)	$ (163.5)	$ (421)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
Insider Trading Arrangements	Feb. 03, 2024 shares	Feb. 03, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		In the fourth quarter of fiscal 2024, the following trading plans were adopted or terminated by an executive officer or director of the Company: Name Title Adopted or Terminated Adoption/Termination Date Plan Start Date Plan End Date Transactions Shares Officers Mark Casper Chief Legal Officer Adopted 1/19/2024 4/19/2024 4/14/2025 Sales 10,000
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Mark Casper [Member]
Trading Arrangements, by Individual
Name	Mark Casper
Title	Chief Legal Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	1/19/2024
Arrangement Duration	360 days
Aggregate Available	10,000	10,000

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Feb. 03, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s fiscal year is the 52- or 53-week period ending on the Saturday closest to January 31. Accordingly, every fifth or sixth fiscal year will have a 53-week period. The additional week in a 53-week year is added to the fourth quarter, making such quarter consist of 14 weeks. Fiscal 2024 had a 53-week period. Fiscal 2023 and fiscal 2022 each had a 52-week period. Certain prior period amounts have been reclassified to conform to current year presentation. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provisions for sales returns and allowances, inventory excess and obsolescence, goodwill and other intangible assets, business combinations, restructuring, income taxes, litigation and other contingencies. Actual results could differ from these estimates, and such differences could affect the results of operations reported in future periods. In the current macroeconomic environment, these estimates could require increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, these estimates may change materially in future periods.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated. The functional currency of the Company and its subsidiaries is the U.S. dollar.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and time deposits.
Investments in Equity Securities	Investments in Equity Securities The Company has equity investments in privately-held companies. If the Company has the ability to exercise significant influence over the investee, but not control, the Company accounts for the investment under the equity method. If the Company does not have the ability to exercise significant influence over the operations of the investee, the Company accounts for the investment under the measurement alternative method. Investments in privately-held companies are included in other non-current assets and subject to impairment review on an ongoing basis. Investments are considered impaired when the fair value is below the investment’s cost basis. This assessment is based on a qualitative and quantitative analysis, including, but not limited to, the investee’s revenue and earnings trends, available cash and liquidity, and the status of the investee’s products and the related market for such products.
Concentration of Credit Risk and Significant Customers	Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to a significant concentration of credit risk consist principally of cash equivalents and accounts receivable. Cash and cash equivalents are maintained with high-quality financial institutions, the composition and maturities of which are regularly monitored by management. The Company believes that the concentration of credit risk in its trade receivables is substantially mitigated by the Company’s credit evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. For customers including distributors, the Company performs ongoing credit evaluations of their financial conditions and limits the amount of credit extended when deemed necessary based upon payment history and their current credit worthiness, but generally requires no collateral. The Company regularly reviews the allowance for bad debt and doubtful accounts by considering factors such as historical experience, credit quality, reasonable and supportable forecasts, age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay. The Company’s accounts receivable was concentrated with three customers at February 3, 2024, who comprise a total of 67% of gross accounts receivable, compared with five customers at January 28, 2023, who represented 55% of gross accounts receivable, respectively. This presentation is at the customer consolidated level. During fiscal 2024, 2023, and 2022, there was no net revenue attributable to a customer, other than one distributor, whose revenues as a percentage of net revenue was 10% or greater of total net revenues. Net revenue attributable to significant distributors whose revenues as a percentage of net revenue was 10% or greater of total net revenues is presented in the following table: Year Ended February 3, January 28, January 29, Distributor: Distributor A 24 % 20 % 15 % The Company continuously monitors the creditworthiness of its distributors and believes these distributors’ sales to diverse end customers and to diverse geographies further serve to mitigate the Company’s exposure to credit risk.
Inventories	Inventories Inventory is stated at the lower of cost or net realizable value, cost being determined under the first-in, first-out method. The total carrying value of the Company’s inventory is reduced for any difference between cost and estimated net realizable value of inventory that is determined to be excess, obsolete or unsellable inventory based upon assumptions about future demand and market conditions. If actual future demand for the Company’s products is less than currently forecasted, the Company may be required to write inventory down below the current carrying value. Once the carrying value of inventory is reduced, it is maintained until the product to which it relates is sold or otherwise disposed. Inventoriable shipping and handling costs are classified as a component of cost of goods sold in the consolidated statements of operations.
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which ranges from 2 to 7 years for machinery and equipment, and 3 to 4 years for computer software, and furniture and fixtures. Buildings are depreciated over an estimated useful life of 30 years and building improvements are depreciated over estimated useful lives of 15 years. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset.
Goodwill	Goodwill Goodwill is recorded when the consideration paid for a business acquisition exceeds the fair value of net tangible and intangible assets acquired. Goodwill is measured and tested for impairment annually on the last business day of the fiscal fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or the Company may determine to proceed directly to the quantitative impairment test. If the Company assesses qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount or if the Company determines not to use the qualitative assessment, then a quantitative impairment test is performed. The quantitative impairment test requires comparing the fair value of the reporting unit to its carrying value, including goodwill. The Company has identified that its business operates as a single operating segment and as a single reporting unit for the purpose of goodwill impairment testing. An impairment exists if the fair value of the reporting unit is lower than its carrying value. If the fair value of the reporting unit is lower than its carrying value, the Company would record an impairment loss in the fiscal quarter in which the determination is made.
Long-Lived Assets and Intangible Assets	Long-Lived Assets and Intangible Assets The Company assesses the impairment of long-lived assets and intangible assets whenever events or changes in circumstances indicate that the carrying amount of long-lived assets may not be recoverable. The Company estimates the future cash flows, undiscounted and without interest charges, expected to be generated by the assets from its use or eventual disposition. If the sum of the expected undiscounted future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Acquisition-related identified intangible assets are amortized on a straight-line basis over their estimated economic lives, except for certain customer contracts and related relationships, which are amortized using an accelerated method of amortization over the expected customer lives. In-process research and development (“IPR&D”) is not amortized until the completion of the related development.
Leases	Leases The Company determines if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease ROU assets also include any initial direct costs and prepayments less lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. As the Company’s leases do not provide an implicit rate, the Company uses its collateralized incremental borrowing rate based on the information available at the lease commencement date, including lease term, in determining the present value of lease payments. Lease expense for these leases is recognized on a straight-line basis over the lease term.
Foreign Currency Transactions	Foreign Currency Transactions The functional currency of all of the Company’s non-United States (“U.S.”) operations is the U.S. dollar. Monetary accounts maintained in currencies other than the U.S. dollar are re-measured using the foreign exchange rate at the balance sheet date. Operational accounts and nonmonetary balance sheet accounts are measured and recorded at the exchange rate in effect at the date of the transaction. The effects of foreign currency re-measurement are reported in current operations.
Revenue Recognition	Revenue Recognition Product revenue is recognized at a point in time when control of the asset is transferred to the customer. Substantially all of the Company’s revenue is derived from product sales. The Company recognizes revenue when it satisfies a performance obligation by transferring control of a product to a customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. For product revenue, the performance obligation is deemed to be the delivery of the product and therefore, the revenue is generally recognized upon shipment to customers, net of accruals for estimated sales returns and rebates. These estimates are based on historical returns, analysis of credit memo data and other known factors. The Company accounts for rebates by recording reductions to revenue for rebates in the same period that the related revenue is recorded. The amount of these reductions is based upon the terms agreed to with the customer. Product revenue on sales made to distributors is recognized upon shipment, net of estimated variable consideration. Variable consideration primarily consists of price discounts, price protection, rebates, and stock rotation programs and is estimated based on a portfolio approach using the expected value method derived from historical data, current economic conditions, and contractual terms. A portion of the Company’s net revenue is derived from sales through third-party logistics providers who maintain warehouses in close proximity to the Company’s customers’ facilities. Revenue from sales through these third-party logistics providers is not recognized until the product is pulled from stock by the customer. The Company’s products are generally subject to warranty, which provides for the estimated future costs of replacement upon shipment of the product. The Company generally warrants that its products sold to its customers will conform to its approved specifications and be free from defects in material and workmanship under normal use and conditions for one year. The Company may offer a longer warranty period in limited situations based on product type and negotiated warranty terms with certain customers. The warranty accrual is estimated primarily based on historical claims compared to historical revenues and assumes that the Company will have to replace products subject to a claim. From time to time, the Company becomes aware of specific warranty situations, and it records specific accruals to cover these exposures.
Business Combinations	Business Combinations The Company allocates the fair value of the purchase consideration of its business acquisitions to the tangible assets, liabilities, and intangible assets acquired, including IPR&D, based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life. Acquisition-related expenses and related restructuring costs are recognized separately from the business combination and are expensed as incurred.
Share-Based Compensation	Stock-Based Compensation Stock-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as expense over the requisite service vesting period. The Company amortizes stock-based compensation expense for time-based awards under the straight-line attribution method over the vesting period. Stock-based compensation expense for performance-based awards is recognized when it becomes probable that the performance conditions will be met. The Company amortizes stock-based compensation expense for performance-based awards using the accelerated method. The fair value of each restricted stock unit is estimated based on the market price of the Company’s common stock on the date of grant less the expected dividend yield. The Company estimates the fair value of stock purchase awards on the date of grant using the Black Scholes option-pricing model. The fair value of performance-based awards based on total shareholder return (“TSR”) are estimated on the date of grant using a Monte Carlo simulation model. Forfeitures are recorded when they occur. Previously recognized expense is reversed for the portion of awards forfeited prior to vesting as and when forfeitures occur.
Comprehensive Loss	Comprehensive Loss Comprehensive loss, net of tax is comprised of net loss and net change in unrealized gains and losses, on cash flow hedges for fiscal 2024. For fiscal 2023 and 2022, there were no reconciling differences between net loss and comprehensive loss.
Accounting for Income Taxes	Accounting for Income Taxes The Company estimates its income taxes in the jurisdictions in which it operates. This process involves estimating the Company’s actual tax expense together with assessing temporary differences resulting from the differing treatment of certain items for tax return and financial statement purposes. These differences result in deferred tax assets and liabilities, which are included in the Company’s consolidated balance sheets. The Company recognizes income taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year, and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law and the effects of future changes in tax laws or rates are not anticipated. Evaluating the need for a valuation allowance for deferred tax assets requires judgment and analysis of all available positive and negative evidence, including recent earnings history and cumulative losses in recent years, reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies to determine whether all or some portion of the deferred tax assets will not be realized. Forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence such as cumulative losses in recent years. Using available evidence and judgment, the Company establishes a valuation allowance for deferred tax assets, when it is determined that it is more likely than not that they will not be realized. Valuation allowances have been provided primarily against U.S. federal and state research and development credits and certain acquired net operating losses and deferred tax assets of foreign subsidiaries. A change in the assessment of the realizability of deferred tax assets may materially impact the Company’s tax provision in the period in which a change of assessment occurs. Taxes due on Global Intangible Low-Taxed Income (“GILTI”) inclusions in U.S. are recognized as a current period expense when incurred. As a multinational corporation, the Company conducts its business in many countries and is subject to taxation in many jurisdictions. The taxation of the business is subject to the application of various and sometimes conflicting tax laws and regulations as well as multinational tax conventions. The Company’s effective tax rate is highly dependent upon the geographic distribution of the Company’s worldwide earnings or losses, the tax laws and regulations in various jurisdictions, the availability of tax incentives, tax credits and loss carryforwards, and the effectiveness of the Company’s tax planning strategies, including the Company’s estimates of the fair value of its intellectual property. The application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty. Tax laws themselves are subject to change as a result of changes in fiscal policy, changes in legislation, and the evolution of regulations and court rulings and tax audits. There can be no assurance that the Company will accurately predict the outcome of audits, and the amounts ultimately paid on resolution of audits could be materially different than the amounts previously included in the Company’s income tax expense and therefore, could have a material impact on its tax provision, results of operations, and cash flows. Consequently, taxing authorities may impose tax assessments or judgments against us that could materially impact the Company’s tax liability and/or its effective income tax rate. The Company is subject to income tax audits by the respective tax authorities in the jurisdictions in which it operates. The Company recognizes the effect of income tax positions only if these positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is more than 50% likely to be realized. Changes in judgment regarding the recognition or measurement of uncertain tax positions are reflected in the period in which the change occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense. The calculation of the Company’s tax liabilities involves the inherent uncertainty associated with complex tax laws. The Company believes it has adequately provided for in its financial statements additional taxes that it estimates may be required to be paid as a result of such examinations. While the Company believes that it has adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than its accrued position. Unpaid tax liabilities, including the interest and penalties, are released pursuant to a final settlement with tax authorities, completion of audit or expiration of various statutes of limitations. The material jurisdictions in which the Company may be subject to examination by tax authorities throughout the world include China, India, Israel, Singapore, Germany, and the United States. The recognition and measurement of current taxes payable or refundable, and deferred tax assets and liabilities require that the Company make certain estimates and judgments. Changes to these estimates or judgments may have a material effect on the Company’s tax provision in a future period.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Pronouncements Not Yet Effective In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280) to improve reportable segment disclosures. The update requires disclosure of incremental segment information on an annual and interim basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) to improve income tax disclosures to enhance transparency and decision usefulness of income tax disclosure. The ASU is effective for fiscal years beginning after December 15, 2024 with updates to be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
Significant Accounting Policies (Tables)	Feb. 03, 2024
Accounting Policies [Abstract]
Schedule of Net Revenue Attributable to Significant Customers	Net revenue attributable to significant distributors whose revenues as a percentage of net revenue was 10% or greater of total net revenues is presented in the following table: Year Ended February 3, January 28, January 29, Distributor: Distributor A 24 % 20 % 15 %

Revenue (Tables)

Revenue (Tables)	12 Months Ended
Revenue (Tables)	Feb. 03, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table summarizes net revenue disaggregated by end market (in millions, except percentages): Year Ended February 3, 2024 % of Total Year Ended January 28, 2023 % of Total Year Ended January 29, 2022 % of Total Net revenue by end market: Data center $ 2,216.7 40 % $ 2,408.8 41 % $ 1,784.7 40 % Enterprise networking 1,228.4 22 % 1,369.2 23 % 907.7 20 % Carrier infrastructure 1,051.9 19 % 1,084.0 18 % 820.4 18 % Consumer 622.4 11 % 701.1 12 % 700.0 16 % Automotive/industrial 388.3 8 % 356.5 6 % 249.6 6 % $ 5,507.7 $ 5,919.6 $ 4,462.4 The following table summarizes net revenue disaggregated by primary geographical market based on destination of shipment (in millions, except percentages): Year Ended February 3, 2024 % of Total Year Ended January 28, 2023 % of Total Year Ended January 29, 2022 % of Total Net revenue based on destination of shipment: China $ 2,371.0 43 % $ 2,486.3 42 % $ 1,970.5 44 % United States 795.6 14 % 690.1 12 % 484.0 11 % Finland 380.4 7 % 189.6 3 % 80.2 2 % Singapore 336.2 6 % 331.7 6 % 220.8 5 % Thailand 329.2 6 % 391.9 7 % 355.3 8 % Malaysia 222.6 4 % 393.2 7 % 276.0 6 % Japan 169.1 3 % 260.0 4 % 222.8 5 % Taiwan 161.9 3 % 289.0 5 % 161.0 4 % Philippines 74.6 1 % 171.5 3 % 213.4 5 % Others 667.1 13 % 716.3 11 % 478.4 10 % $ 5,507.7 $ 5,919.6 $ 4,462.4 The following table summarizes net revenue disaggregated by customer type (in millions, except percentages): Year Ended February 3, 2024 % of Total Year Ended January 28, 2023 % of Total Year Ended January 29, 2022 % of Total Net revenue by customer type: Direct customers $ 3,469.5 63 % $ 3,949.6 67 % $ 3,314.5 74 % Distributors 2,038.2 37 % 1,970.0 33 % 1,147.9 26 % $ 5,507.7 $ 5,919.6 $ 4,462.4

Debt (Tables)

Debt (Tables)	12 Months Ended
Debt (Tables)	Feb. 03, 2024
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	The following table summarizes the Company’s outstanding debt at February 3, 2024 and January 28, 2023 (in millions): February 3, January 28, Face Value Outstanding: 2024 Term Loan - 3-Year Tranche $ — $ 735.0 2026 Term Loan - 5-Year Tranche 700.0 787.5 Term Loan Total 700.0 1,522.5 4.200% MTG/MTI 2023 Senior Notes — 500.0 4.875% MTG/MTI 2028 Senior Notes 499.9 499.9 1.650% 2026 Senior Notes 500.0 500.0 2.450% 2028 Senior Notes 750.0 750.0 5.750% 2029 Senior Notes 500.0 — 2.950% 2031 Senior Notes 750.0 750.0 5.950% 2033 Senior Notes 500.0 — Senior Notes Total 3,499.9 2,999.9 Total borrowings $ 4,199.9 $ 4,522.4 Less: Unamortized debt discount and issuance cost (34.0) (30.3) Net carrying amount of debt $ 4,165.9 $ 4,492.1 Less: Current portion (1) 107.3 584.4 Non-current portion $ 4,058.6 $ 3,907.7 (1)
Aggregate Future Contractual Maturities of Debt	As of February 3, 2024, the aggregate future contractual maturities of the Company’s outstanding debt, at face value, were as follows (in millions): Fiscal Year Amount 2025 $ 109.4 2026 131.2 2027 959.4 2028 — 2029 1,249.9 Thereafter 1,750.0 Total $ 4,199.9

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Feb. 03, 2024
Leases [Abstract]
Schedule of Lease Expense and Supplemental Cash Flow Information	Lease expense and supplemental cash flow information are as follows (in millions): Year Ended February 3, January 28, January 29, Operating lease expense $ 62.0 $ 49.6 $ 61.7 Cash paid for amounts included in the measurement of operating lease liabilities $ 53.5 $ 41.9 $ 45.1 Right-of-use assets obtained in exchange for lease obligation $ 34.1 $ 107.7 $ 95.4
Schedule of Maturities of Operating Lease Liabilities	The aggregate future lease payments for operating leases as of February 3, 2024 are as follows (in millions): Fiscal Year Operating Leases Sublease Income 2025 $ 47.8 $ 5.5 2026 43.4 5.7 2027 39.7 5.9 2028 33.1 4.1 2029 23.7 2.2 Thereafter 86.7 4.1 Total lease payments 274.4 27.5 Less: imputed interest 39.0 Present value of lease liabilities $ 235.4
Schedule of Average Lease Terms And Discount Rates	Average lease terms and discount rates were as follows: February 3, January 28, Weighted-average remaining lease term (years) 7.3 7.0 Weighted-average discount rate 4.0 % 3.7 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
Commitments and Contingencies (Tables)	Feb. 03, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligation, Fiscal Year Maturity	Total future unconditional purchase commitments as of February 3, 2024, are as follows (in millions): Fiscal Year Purchase Commitments to Technology 2025 $ 820.5 $ 149.9 2026 517.0 75.5 2027 374.6 39.2 2028 185.5 36.7 2029 139.3 38.7 Thereafter 394.2 118.2 Total unconditional purchase commitments $ 2,431.1 $ 458.2

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
Business Combinations (Tables)	Feb. 03, 2024
Business Combination and Asset Acquisition [Abstract]
Schedule of Total Merger Consideration	The following table summarized the total merger consideration (in millions): Common stock issued or to be issued $ 971.0 Stock consideration for replacement equity awards attributable to pre-combination service 33.2 Total merger consideration $ 1,004.2 The following table summarized the total merger consideration (in millions): Cash consideration $ 3,673.2 Common stock issued 5,917.8 Stock consideration for replacement equity awards attributable to pre-combination service 82.3 Equity component of convertible debt 244.2 Total merger consideration $ 9,917.5
Schedule of Purchase Price Allocation	The purchase price allocation is as follows (in millions): Cash and cash equivalents $ 60.4 Inventories 70.0 Goodwill 462.4 Acquired intangible assets, net 433.0 Other, net (21.6) Total merger consideration $ 1,004.2 The purchase price allocation is as follows (in millions): Cash and cash equivalents $ 72.3 Accounts receivable, net 99.7 Inventories 270.4 Prepaid expenses and other current assets 213.3 Property and equipment, net 98.5 Acquired intangible assets, net 4,420.0 Other non-current assets 96.6 Goodwill 5,688.4 Accounts payable and accrued liabilities (189.8) Convertible debt - short-term (313.7) Convertible debt - long-term (240.3) Other non-current liabilities (297.9) Total merger consideration $ 9,917.5
Schedule of Supplemental Pro Forma Financial Information	The unaudited supplemental pro forma financial information for the periods presented is as follows (in millions): Year Ended January 29, Pro forma net revenue $ 4,638.5 Pro forma net loss $ (211.9)

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets, Net (Tables)	12 Months Ended
Goodwill and Acquired Intangible Assets, Net (Tables)	Feb. 03, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets by Major Class	In connection with the Innovium acquisition on October 5, 2021, the Company acquired $433.0 million of intangible assets as follows (in millions, except for weighted-average useful life as of acquisition date): Preliminary Estimated Asset Fair Value Weighted-Average Useful Life (Years) Developed technology $ 274.0 8.0 Customer contracts and related relationships 66.0 8.0 IPR&D 93.0 n/a $ 433.0 In connection with the Inphi acquisition on April 20, 2021, the Company acquired $4.4 billion of intangible assets as follows (in millions, except for weighted-average useful life as of acquisition date): Preliminary Estimated Asset Fair Value Weighted-Average Useful Life (Years) Developed technology $ 2,010.0 6.0 Customer contracts and related relationships 1,470.0 6.0 Order backlog 70.0 0.8 Trade name 50.0 5.0 IPR&D 820.0 n/a $ 4,420.0 As of February 3, 2024 and January 28, 2023, net carrying amounts excluding fully amortized intangible assets are as follows (in millions, except for weighted-average remaining amortization period): February 3, 2024 Gross Carrying Accumulated Net Carrying Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 4,989.0 $ (2,613.5) $ 2,375.5 3.8 Customer contracts and related relationships 2,179.0 (1,191.5) 987.5 3.3 Trade names 50.0 (27.9) 22.1 2.2 Total acquired amortizable intangible assets 7,218.0 (3,832.9) 3,385.1 3.6 IPR&D 619.0 — 619.0 n/a Total acquired intangible assets $ 7,837.0 $ (3,832.9) $ 4,004.1 January 28, 2023 Gross Carrying Accumulated Net Carrying Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 5,078.0 $ (2,014.5) $ 3,063.5 4.7 Customer contracts and related relationships 2,179.0 (853.2) 1,325.8 4.2 Trade names 66.0 (32.3) 33.7 3.1 Total acquired amortizable intangible assets 7,323.0 (2,900.0) 4,423.0 4.5 IPR&D 679.0 — 679.0 n/a Total acquired intangible assets $ 8,002.0 $ (2,900.0) $ 5,102.0
Schedule of Indefinite-Lived Intangible Assets	As of February 3, 2024 and January 28, 2023, net carrying amounts excluding fully amortized intangible assets are as follows (in millions, except for weighted-average remaining amortization period): February 3, 2024 Gross Carrying Accumulated Net Carrying Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 4,989.0 $ (2,613.5) $ 2,375.5 3.8 Customer contracts and related relationships 2,179.0 (1,191.5) 987.5 3.3 Trade names 50.0 (27.9) 22.1 2.2 Total acquired amortizable intangible assets 7,218.0 (3,832.9) 3,385.1 3.6 IPR&D 619.0 — 619.0 n/a Total acquired intangible assets $ 7,837.0 $ (3,832.9) $ 4,004.1 January 28, 2023 Gross Carrying Accumulated Net Carrying Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 5,078.0 $ (2,014.5) $ 3,063.5 4.7 Customer contracts and related relationships 2,179.0 (853.2) 1,325.8 4.2 Trade names 66.0 (32.3) 33.7 3.1 Total acquired amortizable intangible assets 7,323.0 (2,900.0) 4,423.0 4.5 IPR&D 679.0 — 679.0 n/a Total acquired intangible assets $ 8,002.0 $ (2,900.0) $ 5,102.0
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of February 3, 2024 (in millions): Fiscal Year Amount 2025 $ 1,052.4 2026 997.5 2027 829.9 2028 273.2 2029 107.1 Thereafter 125.0 $ 3,385.1

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Feb. 03, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	The tables below set forth, by level, the Company’s assets that are measured at fair value on a recurring basis. The tables do not include assets that are measured at historical cost or any basis other than fair value (in millions): Fair Value Measurements at February 3, 2024 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits — 2.6 — 2.6 Prepaid expenses and other current assets: Foreign currency forward contracts — 1.2 — 1.2 Other non-current assets: Marketable equity investments 9.3 — — 9.3 Severance pay fund — 0.5 — 0.5 Total assets $ 9.3 $ 4.3 $ — $ 13.6 Fair Value Measurements at January 28, 2023 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits $ — $ 150.7 $ — $ 150.7 Other non-current assets: Marketable equity investments 3.2 — — 3.2 Severance pay fund — 0.7 — 0.7 Total assets $ 3.2 $ 151.4 $ — $ 154.6

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
Restructuring (Tables)	Feb. 03, 2024
Restructuring and Related Activities [Abstract]
Reconciliation of Beginning and Ending Restructuring Liability Balances by Major Type of Costs	The following table provides a summary of restructuring related charges as presented in the consolidated statements of operations (in millions): Year Ended February 3, January 28, January 29, Cost of goods sold $ — $ — $ (0.8) Restructuring related charges 131.1 21.6 32.4 $ 131.1 $ 21.6 $ 31.6 The following table presents details related to the restructuring related charges as presented in the consolidated statements of operations (in millions): Year Ended February 3, January 28, January 29, Employee severance $ 93.9 $ 15.5 $ 24.1 Impairment and write-off of assets Purchased IP licenses 28.6 — — Other 8.6 6.1 7.5 $ 131.1 $ 21.6 $ 31.6
Summary of Restructuring and Other Related Charges	The following table sets forth a reconciliation of the beginning and ending restructuring liability balances by each major type of costs associated with the restructuring charges (in millions): July 2018 November 2019 Restructuring July 2020 Fiscal 2022 Restructuring Fiscal 2023 Restructuring Fiscal 2024 Restructuring Employee Severance Other Employee Severance Other Employee Severance Other Employee Severance Other Employee Severance Other Employee Severance Other Total Balance at January 29, 2022 $ 0.4 $ 1.1 $ 0.2 $ — $ 0.3 $ 1.5 $ 2.1 $ — $ — $ — $ — $ — $ 5.6 Charges — 5.5 — — — 0.3 — — 15.4 0.4 — — 21.6 Net Cash payments (0.4) — (0.2) — (0.3) (1.4) (2.1) — (11.8) (0.4) — — (16.6) Non-cash items — (5.6) — — — — — — — — — — (5.6) Balance at January 28, 2023 — 1.0 — — — 0.4 — — 3.6 — — — 5.0 Charges — 0.3 — — — — — — — — 93.9 36.9 131.1 Net Cash payments — 2.4 — — — (0.4) — — (3.6) — (78.4) (24.5) (104.5) Non-cash items — (2.9) — — — — — — — — — (11.7) (14.6) Balance at February 3, 2024 — 0.8 — — — — — — — — 15.5 0.7 17.0 Less: non-current portion — 0.6 — — — — — — — — — 0.3 0.9 Current portion $ — $ 0.2 $ — $ — $ — $ — $ — $ — $ — $ — $ 15.5 $ 0.4 $ 16.1

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	12 Months Ended
Stockholders’ Equity (Tables)	Feb. 03, 2024
Equity [Abstract]
Schedule of Repurchases	A summary of the stock repurchase activity under the stock repurchase program, reported based on the trade date, is summarized as follows (in millions, except per share amounts): Shares Weighted- Amount Cumulative balance at January 30, 2021 308.1 $ 13.86 $ 4,270.0 Repurchase of common stock under the stock repurchase program — $ — $ — Cumulative balance at January 29, 2022 308.1 $ 13.86 $ 4,270.0 Repurchase of common stock under the stock repurchase program 2.3 $ 49.93 $ 115.0 Cumulative balance at January 28, 2023 310.4 $ 14.12 $ 4,385.0 Repurchase of common stock under the stock repurchase program 2.5 $ 61.51 $ 150.0 Cumulative balance at February 3, 2024 312.9 $ 14.49 $ 4,535.0

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
Employee Benefit Plans (Tables)	Feb. 03, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	The following table summarizes stock-based compensation expense (in millions): Year Ended February 3, January 28, January 29, Cost of goods sold $ 49.1 $ 43.3 $ 31.1 Research and development 411.1 372.4 273.2 Selling, general and administrative 149.6 136.7 173.2 Total stock-based compensation $ 609.8 $ 552.4 $ 477.5
Schedule of Nonvested Share Activity	A summary of restricted stock and stock unit activity for time-based and performance-based awards is as follows (in millions, except per share amounts): Time-Based Performance-Based Number of Weighted-Average Number of Weighted-Average Unvested Balance at January 28, 2023 15.5 $ 51.71 3.1 $ 47.51 Granted 14.2 $ 41.50 3.3 $ 37.78 Vested (11.1) $ 47.19 (1.6) $ 36.16 Canceled/Forfeited (2.4) $ 48.76 (0.2) $ 50.76 Unvested Balance at February 3, 2024 16.2 $ 46.36 4.6 $ 44.17
Schedule of Stock Option Activity	Stock option activity under the Company’s Option Plan and other stock incentive plans mentioned above (excluding the ESPP) is included in the following table (in millions, except for per share amounts and weighted-average contractual term): Number of Weighted- Weighted- Average Contractual Term (Years) Aggregate Intrinsic Value Balance at January 28, 2023 1.9 $ 12.80 1.8 $ 60.2 Granted — $ — Exercised (1.2) $ 12.06 Canceled/Forfeited — $ — Balance at February 3, 2024 0.7 $ 14.00 1.8 $ 38.6 Exercisable at February 3, 2024 0.7 $ 14.00 1.8 $ 38.6 Vested or expected to vest at February 3, 2024 0.7 $ 14.00 1.8 $ 38.6
Weighted Average Assumptions Used to Calculate Fair Value Awards	The following weighted-average assumptions were used for each respective period to calculate the fair value of common stock to be issued under the ESPP on the date of grant using the Black-Scholes option pricing model: Year Ended February 3, January 28, January 29, Employee Stock Purchase Plan: Estimated fair value $ 21.44 $ 17.42 $ 24.14 Expected volatility 55 % 58 % 46 % Expected term (in years) 1.3 1.3 1.3 Risk-free interest rate 5.0 % 4.1 % 0.2 % Expected dividend yield 0.4 % 0.6 % 0.4 % The following weighted-average assumptions were used for each respective period to calculate the fair value of common stock to be issued under PRSU awards on the date of grant using the Monte Carlo pricing model: Year Ended February 3, January 28, January 29, PRSUs: Expected term (in years) 3.5 3.0 3.0 Expected volatility 50 % 51 % 44 % Average correlation coefficient of peer companies 0.7 0.7 0.6 Risk-free interest rate 3.7 % 3.3 % 0.3 % Expected dividend yield 0.6 % 0.5 % 0.5 %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Feb. 03, 2024
Income Tax Disclosure [Abstract]
Schedule of US and non US Components of Income Before Income Tax Expense (Benefit)	The U.S. and non-U.S. components of income (loss) from continuing operations before income taxes consist of the following (in millions): Year Ended February 3, January 28, January 29, U.S. operations $ (383.3) $ (452.7) $ (621.2) Non-U.S. operations (375.4) 537.8 137.7 Income (loss) before income taxes $ (758.7) $ 85.1 $ (483.5)
Schedule of Provision (Benefit) for Income Taxes	The provision (benefit) for income taxes consists of the following (in millions): Year Ended February 3, January 28, January 29, Current income tax provision (benefit): Federal $ (1.0) $ 57.8 $ — State (2.1) 3.3 0.7 Foreign 27.0 137.1 30.7 Total current income tax provision 23.9 198.2 31.4 Deferred income tax provision (benefit): Federal 186.9 (118.8) (83.4) State 4.7 (17.5) (9.2) Foreign (40.8) 186.7 (1.3) Total deferred income tax provision (benefit) 150.8 50.4 (93.9) Total provision (benefit) for income taxes $ 174.7 $ 248.6 $ (62.5)
Schedule of Effective Income Tax Rate Reconciliation	The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income (loss) before income taxes as follows (in millions): Year Ended February 3, January 28, January 29, Provision (benefit) at U.S. statutory rate $ (159.3) $ 17.9 $ (101.5) State taxes, net of federal benefit 2.5 (13.8) (8.1) Difference in U.S. and non-U.S. tax rates 69.5 (16.0) 1.7 Foreign income inclusion in U.S. 220.0 194.4 54.1 Change in federal valuation allowance 92.4 (73.8) 62.7 Federal research and development credits (88.0) (96.1) (60.7) Stock-based compensation (0.5) (2.0) (70.9) Non-deductible compensation 15.8 15.1 47.9 Intellectual property transaction 15.3 — — Uncertain tax positions 1.0 (16.5) (1.5) Federal tax attribute expiration — 5.8 — Singapore incentive rate extension — 213.6 — Transaction costs — 0.4 5.7 Israel income tax recapture — 18.3 — Other 6.0 1.3 8.1 Total provision (benefit) for income taxes $ 174.7 $ 248.6 $ (62.5)
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities consist of the following (in millions): February 3, January 28, Deferred tax assets: Net operating losses $ 107.9 $ 124.9 Federal and California income tax credits 1,056.6 917.4 Intangible assets 580.0 684.7 Lease liabilities 44.9 49.7 Capitalized R&D — 253.8 Other 86.4 65.2 Gross deferred tax assets 1,875.8 2,095.7 Valuation allowance (1,099.0) (961.7) Total deferred tax assets 776.8 1,134.0 Deferred tax liabilities: Intangible assets (421.4) (648.5) Fixed assets (39.0) (13.6) Unremitted earnings of non-U.S. subsidiaries (26.7) (24.7) Right of use assets (36.5) (45.5) Total deferred tax liabilities (523.6) (732.3) Net deferred tax assets $ 253.2 $ 401.7 The deferred tax assets and liabilities based on tax jurisdictions are presented on the Company’s consolidated balance sheets as follows (in millions): February 3, January 28, Non-current deferred tax assets $ 311.9 $ 465.9 Non-current deferred tax liabilities (58.7) (64.2) Net deferred tax assets $ 253.2 $ 401.7
Schedule of Unrecognized Tax Benefits Reconciliation	The following table reflects changes in the unrecognized tax benefits (in millions): Year Ended February 3, January 28, January 29, Unrecognized tax benefits as of the beginning of the period $ 317.5 $ 334.0 $ 242.2 Increases related to acquired tax positions — — 94.6 Increases related to prior year tax positions — 2.0 1.5 Decreases related to prior year tax positions (0.8) (16.4) — Increases related to current year tax positions 163.1 6.8 7.7 Settlements (1.0) — (5.9) Lapse in the statute of limitations (1.8) (8.6) (5.6) Foreign exchange gain (0.5) (0.3) (0.5) Gross amounts of unrecognized tax benefits as of the end of the period $ 476.5 $ 317.5 $ 334.0

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	12 Months Ended
Net Loss Per Share (Tables)	Feb. 03, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share	The computations of basic and diluted net loss per share are presented in the following table (in millions, except per share amounts): Year Ended February 3, January 28, January 29, Numerator: Net loss $ (933.4) $ (163.5) $ (421.0) Denominator: Weighted-average shares — basic 861.3 851.4 796.9 Effect of dilutive securities: Stock-based awards — — — Weighted-average shares — diluted 861.3 851.4 796.9 Net loss per share: Basic $ (1.08) $ (0.19) $ (0.53) Diluted $ (1.08) $ (0.19) $ (0.53)
Schedule of Anti-dilutive Potential Shares	Anti-dilutive potential shares are presented in the following table (in millions): Year Ended February 3, January 28, January 29, Weighted-average shares outstanding: Stock-based awards 10.9 21.0 16.1 Convertible debt — — 0.5

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	12 Months Ended
Segment and Geographic Information (Tables)	Feb. 03, 2024
Segment Reporting [Abstract]
Schedule of Long-Lived Asset Information Based on Geographic Region	The following table presents long-lived asset information based on the physical location of the assets by geographic region (in millions): February 3, January 28, Property and equipment, net: United States $ 518.6 $ 418.6 Singapore 159.7 94.5 Israel 33.0 18.2 India 20.7 15.6 China 2.3 10.9 Others 21.7 19.6 $ 756.0 $ 577.4

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	12 Months Ended
Supplemental Financial Information (Tables)	Feb. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	February 3, January 28, Cash and cash equivalents: Cash $ 948.2 $ 760.3 Cash equivalents: Time deposits 2.6 150.7 Cash and cash equivalents $ 950.8 $ 911.0
Schedule of Accounts Receivable, Net	February 3, January 28, Accounts receivable, net: Accounts receivable $ 1,123.6 $ 1,194.3 Less: Doubtful accounts (2.0) (2.1) Accounts receivable, net $ 1,121.6 $ 1,192.2
Schedule of Inventories	February 3, January 28, Inventories: Work-in-process $ 523.8 $ 756.3 Finished goods 340.6 312.0 Inventories $ 864.4 $ 1,068.3
Schedule of Property and Equipment, Net	February 3, January 28, Property and equipment, net: Machinery and equipment $ 1,376.2 $ 1,083.9 Land, buildings, and leasehold improvements 312.4 306.2 Computer software 116.5 114.5 Furniture and fixtures 31.7 30.9 1,836.8 1,535.5 Less: Accumulated depreciation (1,080.8) (958.1) Property and equipment, net $ 756.0 $ 577.4
Schedule of Other Non-current Assets	February 3, January 28, Other non-current assets: Prepaid ship and debit $ 547.6 $ 481.3 Technology licenses (1) 350.6 439.5 Prepayments on supply capacity reservation agreements 302.5 282.3 Operating right-of-use assets 203.6 211.3 Non-marketable equity investments 45.8 36.1 Other 56.8 58.3 Other non-current assets $ 1,506.9 $ 1,508.8 (1)
Schedule of Accrued Liabilities	February 3, January 28, Accrued liabilities: Variable consideration estimates (1) $ 610.7 $ 572.8 Technology license obligations 105.7 119.1 Accrued legal reserve 76.5 102.0 Deferred revenue 43.2 45.2 Accrued interest payable 41.3 22.1 Lease liabilities - current portion 39.4 43.8 Accrued warranty expense 25.5 2.4 Deferred non-recurring engineering credits 21.7 20.0 Accrued income tax payable 17.8 118.4 Other 51.1 46.2 Accrued liabilities $ 1,032.9 $ 1,092.0 (1) Substantially all of the variable consideration estimate is comprised of the ship & debit accrual reserve, but also includes estimated customer returns, price discounts, price protection, rebates, and stock rotation programs.
Schedule of Other Non-current Liabilities	February 3, January 28, Other non-current liabilities: Technology license obligations $ 196.5 $ 267.0 Lease liabilities - non-current 196.0 201.6 Deferred tax liabilities 58.7 64.2 Non-current income taxes payable 56.6 28.5 Other 16.5 29.2 Other non-current liabilities $ 524.3 $ 590.5
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)	The changes in accumulated other comprehensive income, net of tax, by components for the comparative period are presented in the following table (in millions): Unrealized Gain Balance at January 29, 2022 $ — Other comprehensive income (loss) before reclassifications (0.9) Amounts reclassified from accumulated other comprehensive income (loss) 0.9 Net current-period other comprehensive income (loss), net of tax — Balance at January 28, 2023 — Other comprehensive income (loss) before reclassifications (1.5) Amounts reclassified from accumulated other comprehensive income (loss) 2.6 Net current-period other comprehensive income (loss), net of tax 1.1 Balance at February 3, 2024 $ 1.1
Schedule of Supplemental Cash Flow Information	Year Ended February 3, January 28, January 29, Supplemental Cash Flow Information: Cash paid for interest $ 173.7 $ 147.9 $ 91.2 Cash paid for income taxes, net $ 120.6 $ 95.9 $ 7.9 Non-Cash Investing and Financing Activities: Non-cash consideration paid and consideration unpaid for the acquisitions $ — $ 9.2 $ 7,231.8 Purchase of software and intellectual property under license obligations $ 56.2 $ 108.9 $ 325.5 Unpaid purchase of property and equipment at end of year $ 80.1 $ 63.2 $ 20.7

Significant Accounting Polici_4

Significant Accounting Policies - Concentration of Credit Risk and Significant Customers (Details) - Customer Concentration Risk - Accounts Receivable	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023
Three Customers
Concentration Risk [Line Items]
Concentration of risk percentage	67%
Five Customers
Concentration Risk [Line Items]
Concentration of risk percentage		55%

Significant Accounting Polici_5

Significant Accounting Policies - Schedule of Net Revenue Attributable to Significant Customers (Details)	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Net Revenue \| Customer Concentration Risk \| Distributor A
Concentration Risk [Line Items]
Concentration of risk percentage	24%	20%	15%

Significant Accounting Polici_6

Significant Accounting Policies - Property and Equipment, Net (Details)	Feb. 03, 2024
Machinery and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	2 years
Machinery and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	7 years
Computer software \| Minimum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	3 years
Computer software \| Maximum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	4 years
Furniture and fixtures \| Minimum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	3 years
Furniture and fixtures \| Maximum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	4 years
Building
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	30 years
Building improvements
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	15 years

Significant Accounting Polici_7

Significant Accounting Policies - Goodwill (Details)	3 Months Ended	12 Months Ended
Significant Accounting Policies - Goodwill (Details)	Feb. 03, 2024 segment reporting_unit	Feb. 03, 2024 segment	Feb. 03, 2024 reporting_unit
Accounting Policies [Abstract]
Number of operating segments	1	1
Number of reportable segments	1	1	1

Significant Accounting Polici_8

Significant Accounting Policies - Revenue Recognition (Details)	12 Months Ended
	Feb. 03, 2024
Accounting Policies [Abstract]
Standard product warranty term	1 year

Revenue - Net Revenue by End Ma

Revenue - Net Revenue by End Market (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Disaggregation of Revenue [Line Items]
Net revenue	$ 5,507.7	$ 5,919.6	$ 4,462.4
Data center
Disaggregation of Revenue [Line Items]
Net revenue	$ 2,216.7	$ 2,408.8	$ 1,784.7
Data center \| Product Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	40%	41%	40%
Enterprise networking
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,228.4	$ 1,369.2	$ 907.7
Enterprise networking \| Product Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	22%	23%	20%
Carrier infrastructure
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,051.9	$ 1,084	$ 820.4
Carrier infrastructure \| Product Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	19%	18%	18%
Consumer
Disaggregation of Revenue [Line Items]
Net revenue	$ 622.4	$ 701.1	$ 700
Consumer \| Product Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	11%	12%	16%
Automotive/industrial
Disaggregation of Revenue [Line Items]
Net revenue	$ 388.3	$ 356.5	$ 249.6
Automotive/industrial \| Product Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	8%	6%	6%

Revenue - Net Revenue Based on

Revenue - Net Revenue Based on Destination of Shipment (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Disaggregation of Revenue [Line Items]
Net revenue	$ 5,507.7	$ 5,919.6	$ 4,462.4
China
Disaggregation of Revenue [Line Items]
Net revenue	$ 2,371	$ 2,486.3	$ 1,970.5
China \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	43%	42%	44%
United States
Disaggregation of Revenue [Line Items]
Net revenue	$ 795.6	$ 690.1	$ 484
United States \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	14%	12%	11%
Finland
Disaggregation of Revenue [Line Items]
Net revenue	$ 380.4	$ 189.6	$ 80.2
Finland \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	7%	3%	2%
Singapore
Disaggregation of Revenue [Line Items]
Net revenue	$ 336.2	$ 331.7	$ 220.8
Singapore \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	6%	6%	5%
Thailand
Disaggregation of Revenue [Line Items]
Net revenue	$ 329.2	$ 391.9	$ 355.3
Thailand \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	6%	7%	8%
Malaysia
Disaggregation of Revenue [Line Items]
Net revenue	$ 222.6	$ 393.2	$ 276
Malaysia \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	4%	7%	6%
Japan
Disaggregation of Revenue [Line Items]
Net revenue	$ 169.1	$ 260	$ 222.8
Japan \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	3%	4%	5%
Taiwan
Disaggregation of Revenue [Line Items]
Net revenue	$ 161.9	$ 289	$ 161
Taiwan \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	3%	5%	4%
Philippines
Disaggregation of Revenue [Line Items]
Net revenue	$ 74.6	$ 171.5	$ 213.4
Philippines \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	1%	3%	5%
Others
Disaggregation of Revenue [Line Items]
Net revenue	$ 667.1	$ 716.3	$ 478.4
Others \| Geographic Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	13%	11%	10%

Revenue - Net Revenue by Custom

Revenue - Net Revenue by Customer Type (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Disaggregation of Revenue [Line Items]
Net revenue	$ 5,507.7	$ 5,919.6	$ 4,462.4
Direct customers
Disaggregation of Revenue [Line Items]
Net revenue	$ 3,469.5	$ 3,949.6	$ 3,314.5
Direct customers \| Customer Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	63%	67%	74%
Distributors
Disaggregation of Revenue [Line Items]
Net revenue	$ 2,038.2	$ 1,970	$ 1,147.9
Distributors \| Customer Concentration Risk \| Net revenue
Disaggregation of Revenue [Line Items]
% of Total	37%	33%	26%

Debt - Summary of Borrowings an

Debt - Summary of Borrowings and Outstanding Debt (Details) - USD ($) $ in Millions				3 Months Ended	12 Months Ended
	Sep. 18, 2023	Apr. 12, 2021	Dec. 07, 2020	Oct. 28, 2023	Feb. 03, 2024	Jan. 28, 2023
Debt Instrument [Line Items]
Total borrowings					$ 4,199.9	$ 4,522.4
Less: Unamortized debt discount and issuance cost					(34)	(30.3)
Net carrying amount of debt					4,165.9	4,492.1
Non-current portion					$ 4,058.6	$ 3,907.7
Debt, weighted average interest rate					6.83%	4.448%
Term Loan
Debt Instrument [Line Items]
Total borrowings					$ 700	$ 1,522.5
Less: Current portion					107.3	584.4
Term Loan \| 2024 Term Loan - 3-Year Tranche
Debt Instrument [Line Items]
Total borrowings					0	735
Debt term (in years)			3 years	3 years
Term Loan \| 2026 Term Loan - 5-Year Tranche
Debt Instrument [Line Items]
Total borrowings					$ 700	787.5
Debt term (in years)			5 years		5 years
Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 3,499.9	2,999.9
Net carrying amount of debt					2,000
Senior Notes \| 4.200% MTG/MTI 2023 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 0	500
Stated interest rate					0%
Senior Notes \| 4.875% MTG/MTI 2028 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 499.9	499.9
Stated interest rate					0%
Senior Notes \| 1.650% 2026 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 500	500
Stated interest rate		1.65%			0.0165%
Debt term (in years)		5 years
Senior Notes \| 2.450% 2028 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 750	750
Stated interest rate		2.45%			0.0245%
Debt term (in years)		7 years
Senior Notes \| 5.750% 2029 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 500	0
Stated interest rate	5.75%				0.0575%
Debt term (in years)	5 years 6 months
Senior Notes \| 2.950% 2031 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 750	750
Stated interest rate		2.95%			0.0295%
Debt term (in years)		10 years
Senior Notes \| 5.950% 2033 Senior Notes
Debt Instrument [Line Items]
Total borrowings					$ 500	$ 0
Stated interest rate	5.95%				0.0595%
Debt term (in years)	10 years

Debt - Term Loan Agreement (Det

Debt - Term Loan Agreement (Details) - USD ($)		3 Months Ended	12 Months Ended
Debt - Term Loan Agreement (Details) - USD ($)	Dec. 07, 2020	Oct. 28, 2023	Feb. 03, 2024	Jan. 28, 2023
Debt Instrument [Line Items]
Total borrowings			$ 4,199,900,000	$ 4,522,400,000
Term Loan
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 1,800,000,000
Total borrowings			700,000,000	1,522,500,000
Term Loan \| 2024 Term Loan - 3-Year Tranche
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 875,000,000
Debt term (in years)	3 years	3 years
Repayments of debt		$ 735,000,000
Total borrowings			$ 0	735,000,000
Term Loan \| 2026 Term Loan - 5-Year Tranche
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 875,000,000
Debt term (in years)	5 years		5 years
Repayments of debt			$ 87,500,000
Effective interest rate			5.111%
Total borrowings			$ 700,000,000	$ 787,500,000
Term Loan \| 2026 Term Loan - 5-Year Tranche \| Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Percentage of principle			1.25%
Term Loan \| 2026 Term Loan - 5-Year Tranche \| Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Percentage of principle			2.50%
Term Loan \| 2026 Term Loan - 5-Year Tranche \| Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Percentage of principle			3.75%
Term Loan \| 2026 Term Loan - 5-Year Tranche \| SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)			1.375%

Debt - Revolving Credit Facilit

Debt - Revolving Credit Facility (Details) - Revolving Credit Facility - Line of Credit - USD ($)		3 Months Ended			12 Months Ended
	Apr. 14, 2023	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Feb. 03, 2024	Dec. 07, 2020
2020 Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity						$ 750,000,000
2023 Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 1,000,000,000
Debt term (in years)	5 years
Unused commitment fee percentage					0.175%
Proceeds from long-term lines of credit			$ 50,000,000	$ 200,000,000
Repayments of lines of credit			$ 50,000,000
2023 Revolving Credit Facility \| Debt Instrument, Redemption, Period One
Line of Credit Facility [Line Items]
Repayments of lines of credit		$ 200,000,000
2023 Revolving Credit Facility \| Debt Instrument, Redemption, Period Two
Line of Credit Facility [Line Items]
Proceeds from long-term lines of credit		$ 50,000,000

Debt - Senior Unsecured Notes (

Debt - Senior Unsecured Notes (Details) - USD ($) $ in Millions					1 Months Ended
	Sep. 18, 2023	Jun. 22, 2023	May 04, 2021	Apr. 12, 2021	Apr. 30, 2021	Feb. 03, 2024	Jan. 28, 2023	Jun. 22, 2018
Debt Instrument [Line Items]
Debt outstanding						$ 4,165.9	$ 4,492.1
Senior Notes
Debt Instrument [Line Items]
Debt outstanding						$ 2,000
Redemption price percentage				101%
5.750% 2029 Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 500
Stated interest rate	5.75%					0.0575%
Debt term (in years)	5 years 6 months
Effective interest rate	5.891%
5.950% 2033 Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 500
Stated interest rate	5.95%					0.0595%
Debt term (in years)	10 years
Effective interest rate	6.082%
Senior Notes Due 2029 and 2033 \| Senior Notes
Debt Instrument [Line Items]
Debt outstanding						$ 1,000
Redemption price percentage	101%
1.650% 2026 Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 500
Stated interest rate				1.65%		0.0165%
Debt term (in years)				5 years
Effective interest rate				1.839%
2.450% 2028 Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 750
Stated interest rate				2.45%		0.0245%
Debt term (in years)				7 years
Effective interest rate				2.554%
2.950% 2031 Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 750
Stated interest rate				2.95%		0.0295%
Debt term (in years)				10 years
Effective interest rate				3.043%
MTG Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Debt outstanding					$ 1,000
MTI and MTG 2023 Notes \| Senior Notes
Debt Instrument [Line Items]
Repayments of senior notes		$ 500
MTI Senior Notes Due 2023 \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount					$ 500
Stated interest rate					4.20%
MTG Senior Notes Due 2023 \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount								$ 500
Stated interest rate								4.20%
Principal amount exchanged			$ 433.9
MTG/MTI Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Debt outstanding						$ 499.9
MTG Senior Notes Due 2028 \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount					$ 500			$ 500
Stated interest rate					4.875%			4.875%
Effective interest rate					4.94%
Principal amount exchanged			$ 479.5
MTI Senior Notes Due 2028 \| Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.875%
Effective interest rate					4.988%
MTI Senior Notes \| Senior Notes
Debt Instrument [Line Items]
Redemption price percentage					101%

Debt - Interest Expense and Fut

Debt - Interest Expense and Future Contractual Maturities (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Debt Disclosure [Abstract]
Interest expense	$ 202.9	$ 159.6	$ 119

Debt - Future Maturities (Detai

Debt - Future Maturities (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Fiscal Year
2025	$ 109.4
2026	131.2
2027	959.4
2028	0
2029	1,249.9
Thereafter	1,750
Total	$ 4,199.9	$ 4,522.4

Leases - Lease Expense and Supp

Leases - Lease Expense and Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Leases [Abstract]
Operating lease expense	$ 62	$ 49.6	$ 61.7
Cash paid for amounts included in the measurement of operating lease liabilities	53.5	41.9	45.1
Right-of-use assets obtained in exchange for lease obligation	$ 34.1	$ 107.7	$ 95.4

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Leases - Narrative (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Leases [Abstract]
Operating lease amortization	$ 37.2	$ 32.5	$ 28.9

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) $ in Millions	Feb. 03, 2024 USD ($)
Operating Leases
2025	$ 47.8
2026	43.4
2027	39.7
2028	33.1
2029	23.7
Thereafter	86.7
Total lease payments	274.4
Less: imputed interest	39
Present value of lease liabilities	235.4
Sublease Income
2025	5.5
2026	5.7
2027	5.9
2028	4.1
2029	2.2
Thereafter	4.1
Total lease payments	$ 27.5

Leases - Schedule of Average Le

Leases - Schedule of Average Lease Terms and Discount Rates (Details)	Feb. 03, 2024	Jan. 28, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	7 years 3 months 18 days	7 years
Weighted-average discount rate	4%	3.70%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Sep. 30, 2021	Oct. 29, 2022	Feb. 03, 2024
Loss Contingencies [Line Items]
Standard warranty period			1 year
Litigation settlement, amount		$ 100
Charges for product related claims			$ 251
Wafers, Substrates, And Other Manufacturing Products
Loss Contingencies [Line Items]
Long-term purchase commitment, amount			2,000
Other commitment			$ 86
Wafers, Substrates, And Other Manufacturing Products \| Minimum
Loss Contingencies [Line Items]
Long-term purchase commitment, period			4 years
Wafers, Substrates, And Other Manufacturing Products \| Maximum
Loss Contingencies [Line Items]
Long-term purchase commitment, period			10 years
Technology License Fees
Loss Contingencies [Line Items]
Long-term purchase commitment, period	10 years
Other commitment	$ 354

Commitments and Contingencies_2

Commitments and Contingencies - Future Minimum Payments Under Technology License Obligations (Details) $ in Millions	Feb. 03, 2024 USD ($)
Purchase Commitments to Foundries and Test & Assembly Partners
Fiscal Year
2025	$ 820.5
2026	517
2027	374.6
2028	185.5
2029	139.3
Thereafter	394.2
Total unconditional purchase commitments	2,431.1
Technology License Fees
Fiscal Year
2025	149.9
2026	75.5
2027	39.2
2028	36.7
2029	38.7
Thereafter	118.2
Total unconditional purchase commitments	$ 458.2

Business Combinations - Narrati

Business Combinations - Narrative (Details) $ / shares in Units, $ in Millions			12 Months Ended
	Oct. 05, 2021 USD ($)	Apr. 20, 2021 USD ($) $ / shares	Feb. 03, 2024 USD ($)	Jan. 28, 2023 USD ($)	Jan. 29, 2022 USD ($)	Jan. 30, 2021 USD ($)
Business Acquisition [Line Items]
Equity issuance costs					$ 8.2
Share-based compensation expense			$ 609.8	$ 552.4	477.5
Interest expense			211.7	170.6	139.3
Selling, general and administrative
Business Acquisition [Line Items]
Share-based compensation expense			149.6	$ 136.7	173.2
Innovium and Inphi \| Pro Forma
Business Acquisition [Line Items]
Acquisition related costs						$ 65.7
Share-based compensation expense						46.7
Adjustment to inventories						233
Interest expense						$ 11.4
Innovium, Inc.
Business Acquisition [Line Items]
Total purchase consideration	$ 1,004.2
Stock consideration	994.2
Fair value of previously held equity interest	10
Acquisition related costs	$ 11.9
Inphi
Business Acquisition [Line Items]
Total purchase consideration		$ 9,917.5
Stock consideration		$ 5,917.8
Cash consideration (in usd per share) \| $ / shares		$ 66
Ratio of common shares issued per acquiree share		2.323
Debt financing costs					39.8
Debt financing costs, current			2.1
Debt financing costs, noncurrent			15.2
Equity issuance costs			$ 8.2
Inphi \| Selling, general and administrative
Business Acquisition [Line Items]
Acquisition related costs					$ 50.8

Business Combinations - Summary

Business Combinations - Summary of Merger Consideration (Innovium) (Details) - USD ($) $ in Millions		12 Months Ended
	Oct. 05, 2021	Jan. 29, 2022
Business Acquisition [Line Items]
Common stock issued or to be issued		$ 6,890.1
Stock consideration for replacement equity awards attributable to pre-combination service		$ 115.6
Innovium, Inc.
Business Acquisition [Line Items]
Common stock issued or to be issued	$ 971
Stock consideration for replacement equity awards attributable to pre-combination service	33.2
Total merger consideration	$ 1,004.2

Business Combinations - Purchas

Business Combinations - Purchase Price Allocation (Innovium) (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023	Oct. 05, 2021
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Goodwill	$ 11,586.9	$ 11,586.9
Innovium, Inc.
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Cash and cash equivalents			$ 60.4
Inventories			70
Goodwill			462.4
Acquired intangible assets, net			433
Other, net			(21.6)
Total merger consideration			$ 1,004.2

Business Combinations - Summa_2

Business Combinations - Summary of Merger Consideration (Inphi) (Details) - USD ($) $ in Millions		12 Months Ended
	Apr. 20, 2021	Jan. 29, 2022
Business Acquisition [Line Items]
Stock consideration for replacement equity awards attributable to pre-combination service		$ 115.6
Inphi
Business Acquisition [Line Items]
Cash consideration	$ 3,673.2
Common stock issued	5,917.8
Stock consideration for replacement equity awards attributable to pre-combination service	82.3
Equity component of convertible debt	244.2
Total merger consideration	$ 9,917.5

Business Combinations - Purch_2

Business Combinations - Purchase Price Allocation (Inphi) (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023	Apr. 20, 2021
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Goodwill	$ 11,586.9	$ 11,586.9
Inphi
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Cash and cash equivalents		72.3
Accounts receivable, net		99.7
Inventories		270.4
Prepaid expenses and other current assets		213.3
Property and equipment, net		98.5
Acquired intangible assets, net		4,420	$ 4,420
Other non-current assets		96.6
Goodwill		5,688.4
Accounts payable and accrued liabilities		(189.8)
Convertible debt - short-term		(313.7)
Convertible debt - long-term		(240.3)
Other non-current liabilities		(297.9)
Total merger consideration		$ 9,917.5

Business Combinations - Supplem

Business Combinations - Supplemental Pro Forma Information (Details) $ in Millions	12 Months Ended
	Jan. 29, 2022 USD ($)
Business Combination and Asset Acquisition [Abstract]
Pro forma net revenue	$ 4,638.5
Pro forma net loss	$ (211.9)

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets, Net - Narrative (Details)	1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Jan. 31, 2022 USD ($)	Feb. 03, 2024 USD ($) segment reporting_unit	Oct. 05, 2021 USD ($)	Feb. 03, 2024 USD ($)	Feb. 03, 2024 USD ($) segment	Feb. 03, 2024 USD ($) reporting_unit	Feb. 03, 2024 USD ($)	Jan. 28, 2023 USD ($)	Jan. 29, 2022 USD ($)
Finite-Lived Intangible Assets [Line Items]
Goodwill acquired								$ 0
Goodwill		$ 11,586,900,000		$ 11,586,900,000	$ 11,586,900,000	$ 11,586,900,000	$ 11,586,900,000	11,586,900,000
Goodwill impairment		$ 0
Divestiture of goodwill							0	$ 0
Weighted average remaining amortization period (years)				3 years 7 months 6 days				4 years 6 months
Amortization of acquired intangible assets							$ 1,097,900,000	$ 1,087,400,000	$ 979,400,000
Number of operating segments \| segment		1			1
Number of reportable segments		1			1	1
Minimum \| IPR&D
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (years)				5 years
Maximum \| IPR&D
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (years)				10 years
Consulting Services Entity Located in India
Finite-Lived Intangible Assets [Line Items]
Consideration transferred								103,200,000
Goodwill								$ 73,600,000
Innovium and Inphi
Finite-Lived Intangible Assets [Line Items]
Goodwill acquired			$ 6,100,000,000
Consulting Services Entity Located In Canada
Finite-Lived Intangible Assets [Line Items]
Consideration transferred	$ 41,800,000
Goodwill	$ 25,500,000

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets, Net - Identifiable Intangible Assets and Weighted Average Useful Life (Details) - USD ($) $ in Millions			12 Months Ended
	Oct. 05, 2021	Apr. 20, 2021	Feb. 03, 2024	Jan. 28, 2023
Indefinite-lived Intangible Assets [Line Items]
Weighted-Average Useful Life (Years)			3 years 7 months 6 days	4 years 6 months
Innovium, Inc.
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value	$ 433
Inphi
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value		$ 4,420		$ 4,420
Developed technologies \| Innovium, Inc.
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value	$ 274
Weighted-Average Useful Life (Years)	8 years
Developed technologies \| Inphi
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value		$ 2,010
Weighted-Average Useful Life (Years)		6 years
Customer contracts and related relationships \| Innovium, Inc.
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value	$ 66
Weighted-Average Useful Life (Years)	8 years
Customer contracts and related relationships \| Inphi
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value		$ 1,470
Weighted-Average Useful Life (Years)		6 years
Order backlog \| Inphi
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value		$ 70
Weighted-Average Useful Life (Years)		9 months 18 days
Trade names \| Inphi
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value		$ 50
Weighted-Average Useful Life (Years)		5 years
IPR&D \| Innovium, Inc.
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value	$ 93
IPR&D \| Inphi
Indefinite-lived Intangible Assets [Line Items]
Preliminary Estimated Asset Fair Value		$ 820

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets, Net - Net Carrying Amounts and Weighted Average Amortization Period (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	$ 7,218	$ 7,323
Accumulated Amortization	(3,832.9)	(2,900)
Net Carrying Amounts	3,385.1	4,423
Gross Carrying Amounts, Total acquired intangible assets	7,837	8,002
Net Carrying Amounts, Total acquired intangible assets	$ 4,004.1	$ 5,102
Weighted-Average Remaining Amortization Period (Years)	3 years 7 months 6 days	4 years 6 months
IPR&D
Acquired Finite-Lived Intangible Assets [Line Items]
IPR&D	$ 619	$ 679
Developed technologies
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	4,989	5,078
Accumulated Amortization	(2,613.5)	(2,014.5)
Net Carrying Amounts	$ 2,375.5	$ 3,063.5
Weighted-Average Remaining Amortization Period (Years)	3 years 9 months 18 days	4 years 8 months 12 days
Customer contracts and related relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	$ 2,179	$ 2,179
Accumulated Amortization	(1,191.5)	(853.2)
Net Carrying Amounts	$ 987.5	$ 1,325.8
Weighted-Average Remaining Amortization Period (Years)	3 years 3 months 18 days	4 years 2 months 12 days
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	$ 50	$ 66
Accumulated Amortization	(27.9)	(32.3)
Net Carrying Amounts	$ 22.1	$ 33.7
Weighted-Average Remaining Amortization Period (Years)	2 years 2 months 12 days	3 years 1 month 6 days

Goodwill and Acquired Intangi_6

Goodwill and Acquired Intangible Assets, Net - Future Amortization (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 1,052.4
2026	997.5
2027	829.9
2028	273.2
2029	107.1
Thereafter	125
Net Carrying Amounts	$ 3,385.1	$ 4,423

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value, Assets (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Assets
Foreign currency forward contracts	$ 1.2
Marketable equity investments	9.3	$ 3.2
Severance pay fund	0.5	0.7
Total assets	13.6	154.6
Time deposits
Assets
Cash equivalents	2.6	150.7
Level 1
Assets
Foreign currency forward contracts	0
Marketable equity investments	9.3	3.2
Severance pay fund	0	0
Total assets	9.3	3.2
Level 1 \| Time deposits
Assets
Cash equivalents	0	0
Level 2
Assets
Foreign currency forward contracts	1.2
Marketable equity investments	0	0
Severance pay fund	0.5	0.7
Total assets	4.3	151.4
Level 2 \| Time deposits
Assets
Cash equivalents	2.6	150.7
Level 3
Assets
Foreign currency forward contracts	0
Marketable equity investments	0	0
Severance pay fund	0	0
Total assets	0	0
Level 3 \| Time deposits
Assets
Cash equivalents	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Non-marketable equity investments	$ 45.8	$ 36.1
Level 2 \| Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated aggregate fair value of debt	$ 3,300	$ 2,700

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Related Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Restructuring Cost and Reserve [Line Items]
Charges	$ 131.1	$ 21.6	$ 31.6
Cost of goods sold
Restructuring Cost and Reserve [Line Items]
Charges	0	0	(0.8)
Restructuring related charges
Restructuring Cost and Reserve [Line Items]
Charges	$ 131.1	$ 21.6	$ 32.4

Restructuring - Statements of O

Restructuring - Statements of Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Restructuring Cost and Reserve [Line Items]
Employee severance	$ 93.9	$ 15.5	$ 24.1
Other	8.6	6.1	7.5
Restructuring related charges	131.1	21.6	31.6
Server Processor Products \| Intellectual Property
Restructuring Cost and Reserve [Line Items]
Purchased IP licenses	$ 28.6	$ 0	$ 0

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Restructuring - Narrative (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	$ 131.1	$ 21.6	$ 31.6
Employee severance	93.9	15.5	24.1
Restructuring related charges	131.1	21.6	32.4
Current portion of restructuring liability	16.1
Non-current portion of restructuring liability	$ 0.9
Fiscal 2023 Plan \| Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring related charges		$ 15.5
Fiscal 2022 Plan \| Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring related charges			$ 24.1

Restructuring - Reconciliation

Restructuring - Reconciliation of Restructuring Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 5	$ 5.6
Charges	131.1	21.6	$ 31.6
Net Cash payments	(104.5)	(16.6)
Non-cash items	(14.6)	(5.6)
Balance at end of period	17	5	5.6
Less: non-current portion	0.9
Current portion	16.1
July 2018 Restructuring \| Employee Severance
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0.4
Charges	0	0
Net Cash payments	0	(0.4)
Non-cash items	0	0
Balance at end of period	0	0	0.4
Less: non-current portion	0
Current portion	0
July 2018 Restructuring \| Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	1	1.1
Charges	0.3	5.5
Net Cash payments	2.4	0
Non-cash items	(2.9)	(5.6)
Balance at end of period	0.8	1	1.1
Less: non-current portion	0.6
Current portion	0.2
November 2019 Restructuring \| Employee Severance
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0.2
Charges	0	0
Net Cash payments	0	(0.2)
Non-cash items	0	0
Balance at end of period	0	0	0.2
Less: non-current portion	0
Current portion	0
November 2019 Restructuring \| Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0
Charges	0	0
Net Cash payments	0	0
Non-cash items	0	0
Balance at end of period	0	0	0
Less: non-current portion	0
Current portion	0
July 2020 Restructuring \| Employee Severance
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0.3
Charges	0	0
Net Cash payments	0	(0.3)
Non-cash items	0	0
Balance at end of period	0	0	0.3
Less: non-current portion	0
Current portion	0
July 2020 Restructuring \| Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0.4	1.5
Charges	0	0.3
Net Cash payments	(0.4)	(1.4)
Non-cash items	0	0
Balance at end of period	0	0.4	1.5
Less: non-current portion	0
Current portion	0
Fiscal 2022 Restructuring \| Employee Severance
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	2.1
Charges	0	0
Net Cash payments	0	(2.1)
Non-cash items	0	0
Balance at end of period	0	0	2.1
Less: non-current portion	0
Current portion	0
Fiscal 2022 Restructuring \| Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0
Charges	0	0
Net Cash payments	0	0
Non-cash items	0	0
Balance at end of period	0	0	0
Less: non-current portion	0
Current portion	0
Fiscal 2023 Restructuring \| Employee Severance
Restructuring Reserve [Roll Forward]
Balance at beginning of period	3.6	0
Charges	0	15.4
Net Cash payments	(3.6)	(11.8)
Non-cash items	0	0
Balance at end of period	0	3.6	0
Less: non-current portion	0
Current portion	0
Fiscal 2023 Restructuring \| Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0
Charges	0	0.4
Net Cash payments	0	(0.4)
Non-cash items	0	0
Balance at end of period	0	0	0
Less: non-current portion	0
Current portion	0
Fiscal 2024 Restructuring \| Employee Severance
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0
Charges	93.9	0
Net Cash payments	(78.4)	0
Non-cash items	0	0
Balance at end of period	15.5	0	0
Less: non-current portion	0
Current portion	15.5
Fiscal 2024 Restructuring \| Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0
Charges	36.9	0
Net Cash payments	(24.5)	0
Non-cash items	(11.7)	0
Balance at end of period	0.7	$ 0	$ 0
Less: non-current portion	0.3
Current portion	$ 0.4

Stockholders_ Equity - Preferre

Stockholders’ Equity - Preferred and Common Stock (Details) - $ / shares	12 Months Ended
	Jan. 28, 2023	Feb. 03, 2024
Equity, Class of Treasury Stock [Line Items]
Preferred stock, shares authorized (in shares)	8,000,000	8,000,000
Preferred stock, par value (in usd per share)	$ 0.002	$ 0.002
Common stock, shares authorized (in shares)	1,300,000,000	1,300,000,000
Common stock, par value (in usd per share)	$ 0.002	$ 0.002
Preferred stock, shares outstanding (in shares)	0	0
Restricted Stock
Equity, Class of Treasury Stock [Line Items]
Issuance of common stock in connection with acquisitions (in shares)	400,000

Stockholders_ Equity - Restrict

Stockholders’ Equity - Restricted Stock Unit Withholdings (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax withholdings related to net share settlement of restricted stock units	$ 223.7		$ 299.9
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares withheld (in shares)	4.3	4.2	4.8
Tax withholdings related to net share settlement of restricted stock units	$ 223.7	$ 227.6	$ 299.9

Stockholders_ Equity - Cash Div

Stockholders’ Equity - Cash Dividends on Shares of Common Stock (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Equity [Abstract]
Cash dividends declared per share (in dollars per share)	$ 0.24	$ 0.24	$ 0.24
Cash dividends paid (in dollars per share)	$ 0.24	$ 0.24	$ 0.24
Payments of dividends	$ 206.8	$ 204.4	$ 191

Stockholders_ Equity - Stock Re

Stockholders’ Equity - Stock Repurchase Program (Details) - USD ($) shares in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022	Mar. 13, 2024	Jan. 30, 2021	Oct. 16, 2018	Nov. 17, 2016	Nov. 16, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share repurchase program, amount authorized						$ 700,000,000	$ 1,000,000,000	$ 3,300,000,000
Number of shares repurchased (in shares)	2.5	2.3	0
Amount of shares repurchased	$ 150,000,000	$ 115,000,000	$ 0
Shares repurchased (in shares)	312.9	310.4	308.1		308.1
Repurchased amount	$ 4,535,000,000	$ 4,385,000,000	$ 4,270,000,000		$ 4,270,000,000
Share repurchase program, remaining available for future share repurchases	$ 299,500,000
Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, additional authorized amount				$ 3,000,000,000
10b5-1 Trading Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares repurchased (in shares)	0.8	0.9
Amount of shares repurchased	$ 50,000,000	$ 50,000,000

Stockholders_ Equity - Stock _2

Stockholders’ Equity - Stock Repurchase Program Roll Forward (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Shares Repurchased
Cumulative balance at beginning of period (in shares)	310.4	308.1	308.1
Repurchase of common stock under the stock repurchase program (in shares)	2.5	2.3	0
Cumulative balance at end of period (in shares)	312.9	310.4	308.1
Weighted- Average Price per Share
Cumulative balance at beginning of period (in dollars per share)	$ 14.12	$ 13.86	$ 13.86
Repurchase of common stock under the stock repurchase program (in dollars per share)	61.51	49.93	0
Cumulative balance at end of period (in dollars per share)	$ 14.49	$ 14.12	$ 13.86
Amount Repurchased
Cumulative balance at beginning of period	$ 4,385	$ 4,270	$ 4,270
Repurchase of common stock under the stock repurchase program	150	115	0
Cumulative balance at end of period	$ 4,535	$ 4,385	$ 4,270

Employee Benefit Plans - 1995 S

Employee Benefit Plans - 1995 Stock Option Plan (Details) - 1995 Stock Option Plan shares in Millions	12 Months Ended
	Feb. 03, 2024 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance, authorized (in shares)	383.4
Number of shares available for future issuance (in shares)	50.6
Award expiration period	10 years
Minimum \| Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Minimum \| Performance-Based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target number of shares	0%
Minimum \| Performance-Based \| Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award service period	3 years
Maximum \| Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Maximum \| Performance-Based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target number of shares	250%
Maximum \| Performance-Based \| Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award service period	5 years

Employee Benefit Plans - Outsid

Employee Benefit Plans - Outside Director Equity Compensation Policy (Details) - Outside Director Equity Compensation Policy - RSUs	12 Months Ended
	Feb. 03, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards, vesting percentage	100%
Equity awards, vesting period	1 year

Employee Benefit Plans - Assume

Employee Benefit Plans - Assumed Employee Stock Compensation Plans (Details) $ in Millions	Feb. 03, 2024 USD ($)
Inphi
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of awards assumed in acquisition	$ 589.7
Pre-acquisition service	161.7
Inphi \| Inphi 2010 EIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense to be recognized	428
Innovium, Inc. \| Innovium 2015 EIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of awards assumed in acquisition	80.9
Pre-acquisition service	39.8
Share-based compensation expense to be recognized	$ 41.1

Employee Benefit Plans - Employ

Employee Benefit Plans - Employee Stock Purchase Plan (Details) - the ESPP $ / shares in Units, shares in Millions, $ in Millions		12 Months Ended
	Apr. 02, 2021	Feb. 03, 2024 USD ($) purchasePeriod $ / shares shares	Jan. 28, 2023 $ / shares shares	Jan. 29, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum subscription rate	15%
Look-back period	24 months
Number of purchase periods \| purchasePeriod		4
Share based payment award purchase period		6 months
Percentage discount of purchase price per share of common shares	85%
Offering period	2 years
Number of shares issued (in shares)		2.4	2.3	2.4
Weighted-average price (in USD per share) \| $ / shares		$ 35.57	$ 37.52	$ 31.96
Unamortized compensation expense \| $		$ 42.7
Number of shares available for future issuance (in shares)		41.5

Employee Benefit Plans - Summar

Employee Benefit Plans - Summary of Share-based Compensation Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 609.8	$ 552.4	$ 477.5
Cost of goods sold
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	49.1	43.3	31.1
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	411.1	372.4	273.2
Selling, general and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 149.6	$ 136.7	$ 173.2

Employee Benefit Plans - Share-

Employee Benefit Plans - Share-based Compensation Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Share-Based Payment Arrangement [Abstract]
Income tax benefits realized from share-based compensation	$ 95.3	$ 89.9	$ 71.8
Share-based compensation capitalized in inventory	18.2	20.3	18.4
Income tax benefits realized related to awards vested or exercised	$ 24.3	$ 21.7	$ 63

Employee Benefit Plans - Restri

Employee Benefit Plans - Restricted Stock Unit Activity (Details) - $ / shares shares in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Time-Based
Number of Shares
Beginning Balance (in shares)	15.5
Granted (in shares)	14.2
Vested (in shares)	(11.1)
Canceled/Forfeited (in shares)	(2.4)
Ending Balance (in shares)	16.2	15.5
Weighted-Average Grant Date Fair Value
Beginning Balance (in dollars per share)	$ 51.71
Granted (in dollars per share)	41.50	$ 55.73	$ 55.47
Vested (in dollars per share)	47.19
Canceled/Forfeited (in dollars per share)	48.76
Ending Balance (in dollars per share)	$ 46.36	$ 51.71
Performance-Based
Number of Shares
Beginning Balance (in shares)	3.1
Granted (in shares)	3.3
Vested (in shares)	(1.6)
Canceled/Forfeited (in shares)	(0.2)
Ending Balance (in shares)	4.6	3.1
Weighted-Average Grant Date Fair Value
Beginning Balance (in dollars per share)	$ 47.51
Granted (in dollars per share)	37.78	$ 45.40	$ 52.97
Vested (in dollars per share)	36.16
Canceled/Forfeited (in dollars per share)	50.76
Ending Balance (in dollars per share)	$ 44.17	$ 47.51

Employee Benefit Plans - Rest_2

Employee Benefit Plans - Restricted Stock and Stock Unit Awards Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Time-Based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value expected to vest	$ 1,100
Granted (in dollars per share)	$ 41.50	$ 55.73	$ 55.47
Fair value of PSRU	$ 523.7	$ 519.6	$ 313.3
Share-based compensation expense to be recognized	$ 688.6
Unrecognized share based compensation cost, weighted-average period of recognition (in years)	2 years
Performance-Based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value expected to vest	$ 309.1
Granted (in dollars per share)	$ 37.78	$ 45.40	$ 52.97
Fair value of PSRU	$ 56	$ 38.5	$ 42.5
Share-based compensation expense to be recognized	$ 127.8
Unrecognized share based compensation cost, weighted-average period of recognition (in years)	2 years

Employee Benefit Plans - Stock

Employee Benefit Plans - Stock Option Plan Activity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023
Number of Shares
Balance at beginning of period (in shares)	1.9
Granted (in shares)	0
Exercised (in shares)	(1.2)
Canceled/Forfeited (in shares)	0
Balance at end of period (in shares)	0.7	1.9
Exercisable (in shares)	0.7
Vested or expected to vest at end of period (in shares)	0.7
Weighted- Average Exercise Price
Balance at beginning of period (in dollars per share)	$ 12.80
Granted (in dollars per share)	0
Exercised (in dollars per share)	12.06
Canceled/Forfeited (in dollars per share)	0
Balance at end of period (in dollars per share)	14	$ 12.80
Exercisable (in dollars per shares)	14
Vested or expected to vest at end of period (in dollars per share)	$ 14
Weighted- Average Contractual Term (Years)
Balance outstanding (in years)	1 year 9 months 18 days	1 year 9 months 18 days
Exercisable (in years)	1 year 9 months 18 days
Vested or expected to vest at end of period (in years)	1 year 9 months 18 days
Aggregate Intrinsic Value
Balance	$ 38.6	$ 60.2
Exercisable	38.6
Vested or expected to vest at end of period	$ 38.6

Employee Benefit Plans - Option

Employee Benefit Plans - Option Plan and Stock Award Activity Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Share-Based Payment Arrangement [Abstract]
Aggregate intrinsic value of stock options exercised	$ 43.5	$ 21.5	$ 43.3

Employee Benefit Plans - Valuat

Employee Benefit Plans - Valuation of Employee Share-Based Awards (Details) - shares	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	0
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	0	0	0

Employee Benefit Plans - Assump

Employee Benefit Plans - Assumptions Used to Calculate Fair Value Awards for ESPP (Details) - $ / shares	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Performance-Based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	50%	51%	44%
Expected term (in years)	3 years 6 months	3 years	3 years
Risk-free interest rate	3.70%	3.30%	0.30%
Expected dividend yield	0.60%	0.50%	0.50%
Average correlation coefficient of peer companies	0.7	0.7	0.6
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated fair value (in dollars per share)	$ 21.44	$ 17.42	$ 24.14
Expected volatility	55%	58%	46%
Expected term (in years)	1 year 3 months 18 days	1 year 3 months 18 days	1 year 3 months 18 days
Risk-free interest rate	5%	4.10%	0.20%
Expected dividend yield	0.40%	0.60%	0.40%

Employee Benefit Plans - Empl_2

Employee Benefit Plans - Employee 401(k) Plans (Details) - USD ($)	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
United States
Defined Contribution Plan Disclosure [Line Items]
Employee pre-tax contributions to 401(k) (as a percent)	5%
Employer match contributions percentage	100%
Maximum contribution per employee	$ 5,000
Matching contributions to employees	$ 15,500,000	$ 15,900,000	$ 14,500,000
United States \| Minimum
Defined Contribution Plan Disclosure [Line Items]
Employee pre-tax contributions to 401(k) (as a percent)	1%
United States \| Maximum
Defined Contribution Plan Disclosure [Line Items]
Employee pre-tax contributions to 401(k) (as a percent)	75%
Foreign Plan
Defined Contribution Plan Disclosure [Line Items]
Matching contributions to employees	$ 11,400,000	$ 11,300,000	$ 11,000,000

Income Taxes - U.S. and Non-U.S

Income Taxes - U.S. and Non-U.S. Components of Income Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Income Tax Disclosure [Abstract]
U.S. operations	$ (383.3)	$ (452.7)	$ (621.2)
Non-U.S. operations	(375.4)	537.8	137.7
Income (loss) before income taxes	$ (758.7)	$ 85.1	$ (483.5)

Income Taxes - Provision (Benef

Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Current income tax provision (benefit):
Federal	$ (1)	$ 57.8	$ 0
State	(2.1)	3.3	0.7
Foreign	27	137.1	30.7
Total current income tax provision	23.9	198.2	31.4
Deferred income tax provision (benefit):
Federal	186.9	(118.8)	(83.4)
State	4.7	(17.5)	(9.2)
Foreign	(40.8)	186.7	(1.3)
Total deferred income tax provision (benefit)	150.8	50.4	(93.9)
Total provision (benefit) for income taxes	$ 174.7	$ 248.6	$ (62.5)

Income Taxes - Reconciliation S

Income Taxes - Reconciliation Statutory Rate and the Effective Tax Rate (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Income Tax Disclosure [Abstract]
Provision (benefit) at U.S. statutory rate	$ (159.3)	$ 17.9	$ (101.5)
State taxes, net of federal benefit	2.5	(13.8)	(8.1)
Difference in U.S. and non-U.S. tax rates	69.5	(16)	1.7
Foreign income inclusion in U.S.	220	194.4	54.1
Change in federal valuation allowance	92.4	(73.8)	62.7
Federal research and development credits	(88)	(96.1)	(60.7)
Stock-based compensation	(0.5)	(2)	(70.9)
Non-deductible compensation	15.8	15.1	47.9
Intellectual property transaction	15.3	0	0
Uncertain tax positions	1	(16.5)	(1.5)
Federal tax attribute expiration	0	5.8	0
Singapore incentive rate extension	0	213.6	0
Transaction costs	0	0.4	5.7
Israel income tax recapture	0	18.3	0
Other	6	1.3	8.1
Total provision (benefit) for income taxes	$ 174.7	$ 248.6	$ (62.5)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Jul. 31, 1999	Apr. 30, 2022	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022	Apr. 14, 2023	Jan. 30, 2021
Income Taxes [Line Items]
Capitalized R&D			$ 0	$ 253.8
R&D tax credits			111.2
Valuation allowance			1,099	961.7
Increase in valuation			137.3
Unrecognized tax benefits			476.5	317.5	$ 334		$ 242.2
Unrecognized tax benefit that would affect the effective income tax rate if recognized			196
Unrecognized tax benefits that would impact deferred tax assets			239.9
Unrecognized tax benefit, interest and penalties accrued			3.8	3.2	3.9
Interest and penalties related to unrecognized tax benefits included in consolidated statements of operation			1.3	1.6	0.6
Cash, cash equivalents and short-term investments			950.8
Unrecognized deferred tax liability on undistributed earnings of foreign subsidiaries			154
Revolving Credit Facility \| 2023 Revolving Credit Facility \| Line of Credit
Income Taxes [Line Items]
Maximum borrowing capacity						$ 1,000
Foreign Subsidiaries
Income Taxes [Line Items]
Cash, cash equivalents and short-term investments			744.1
Federal
Income Taxes [Line Items]
Net operating loss carryforwards			629.7
Federal \| Research Tax Credit
Income Taxes [Line Items]
Tax credit carryforwards			621.4
State \| California
Income Taxes [Line Items]
Net operating loss carryforwards			818.3
State \| California \| Research Tax Credit
Income Taxes [Line Items]
Tax credit carryforwards			698.7
State \| Other State
Income Taxes [Line Items]
Net operating loss carryforwards			243.9
State \| Other State \| Research and Investment Tax Credit
Income Taxes [Line Items]
Tax credit carryforwards			43.1
Foreign
Income Taxes [Line Items]
Net operating loss carryforwards			2.1
Foreign \| Research Tax Credit
Income Taxes [Line Items]
Tax credit carryforwards			13.8
Economic Development Board of Singapore Pioneer Status
Income Taxes [Line Items]
Expiration of tax exemption, period	10 years
Extended term, period		5 years
Tax holidays, tax savings amount					$ 11.8
Tax holidays, per share effect on earnings (in dollars per share)					$ 0.01
Israeli Encouragement of Investments Law Special Technology Enterprise Regime
Income Taxes [Line Items]
Tax holidays, tax savings amount			$ 8.7	$ 11.2
Tax holidays, per share effect on earnings (in dollars per share)			$ 0.01	$ 0.01
Research and Development Tax Credits
Income Taxes [Line Items]
Valuation allowance			$ 111.2

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Deferred tax assets:
Net operating losses	$ 107.9	$ 124.9
Federal and California income tax credits	1,056.6	917.4
Intangible assets	580	684.7
Lease liabilities	44.9	49.7
Capitalized R&D	0	253.8
Other	86.4	65.2
Gross deferred tax assets	1,875.8	2,095.7
Valuation allowance	(1,099)	(961.7)
Total deferred tax assets	776.8	1,134
Deferred tax liabilities:
Intangible assets	(421.4)	(648.5)
Fixed assets	(39)	(13.6)
Unremitted earnings of non-U.S. subsidiaries	(26.7)	(24.7)
Right of use assets	(36.5)	(45.5)
Total deferred tax liabilities	(523.6)	(732.3)
Net deferred tax assets	$ 253.2	$ 401.7

Income Taxes - Classification o

Income Taxes - Classification of Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Income Tax Disclosure [Abstract]
Non-current deferred tax assets	$ 311.9	$ 465.9
Non-current deferred tax liabilities	(58.7)	(64.2)
Net deferred tax assets	$ 253.2	$ 401.7

Income Taxes - Changes in Unrec

Income Taxes - Changes in Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits as of the beginning of the period	$ 317.5	$ 334	$ 242.2
Increases related to acquired tax positions	0	0	94.6
Increases related to prior year tax positions	0	2	1.5
Decreases related to prior year tax positions	(0.8)	(16.4)	0
Increases related to current year tax positions	163.1	6.8	7.7
Settlements	(1)	0	(5.9)
Lapse in the statute of limitations	(1.8)	(8.6)	(5.6)
Foreign exchange gain	(0.5)	(0.3)	(0.5)
Gross amounts of unrecognized tax benefits as of the end of the period	$ 476.5	$ 317.5	$ 334

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Numerator:
Net loss	$ (933.4)	$ (163.5)	$ (421)
Denominator:
Weighted average shares — basic (in shares)	861.3	851.4	796.9
Effect of dilutive securities:
Share-based awards (in shares)	0	0	0
Weighted average shares — diluted (in shares)	861.3	851.4	796.9
Net loss per share:
Net loss per share - Basic (in dollars per share)	$ (1.08)	$ (0.19)	$ (0.53)
Net loss per share - Diluted (in dollars per share)	$ (1.08)	$ (0.19)	$ (0.53)

Net Loss Per Share - Anti-dilut

Net Loss Per Share - Anti-dilutive Potential Shares (Details) - shares shares in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Stock-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average shares outstanding, amount	10.9	21	16.1
Convertible debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average shares outstanding, amount	0	0	0.5

Segment and Geographic Inform_3

Segment and Geographic Information - Narrative (Details)	3 Months Ended	12 Months Ended
Segment and Geographic Information - Narrative (Details)	Feb. 03, 2024 reporting_unit	Feb. 03, 2024 reporting_unit	Feb. 03, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	1	1	1

Segment and Geographic Inform_4

Segment and Geographic Information - Long-Lived Asset Information (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	$ 756	$ 577.4
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	518.6	418.6
Singapore
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	159.7	94.5
Israel
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	33	18.2
India
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	20.7	15.6
China
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	2.3	10.9
Others
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	$ 21.7	$ 19.6

Supplemental Financial Inform_3

Supplemental Financial Information - Cash and Cash Equivalents (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Cash and cash equivalents:
Cash	$ 948.2	$ 760.3
Cash equivalents:
Time deposits	2.6	150.7
Cash and cash equivalents	$ 950.8	$ 911

Supplemental Financial Inform_4

Supplemental Financial Information - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Finite-Lived Intangible Assets [Line Items]
Short-term, highly liquid investments	$ 2.6	$ 150.7
Trade accounts receivable sold	335.7
Factored receivables outstanding	155.9
Depreciation expense	148.2	126.8	$ 113.5
Amortization and write-off of acquired intangible assets	1,097.9	1,087.4	979.4
Other comprehensive income	1.1	0	0
Technology and Other Licenses
Finite-Lived Intangible Assets [Line Items]
Amortization and write-off of acquired intangible assets	$ 177.1	$ 189.5	$ 149.5

Supplemental Financial Inform_5

Supplemental Financial Information - Accounts Receivable, Net (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Accounts receivable, net:
Accounts receivable	$ 1,123.6	$ 1,194.3
Less: Doubtful accounts	(2)	(2.1)
Accounts receivable, net	$ 1,121.6	$ 1,192.2

Supplemental Financial Inform_6

Supplemental Financial Information - Inventories (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Inventories:
Work-in-process	$ 523.8	$ 756.3
Finished goods	340.6	312
Inventories	$ 864.4	$ 1,068.3

Supplemental Financial Inform_7

Supplemental Financial Information - Property and Equipment, Net (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,836.8	$ 1,535.5
Less: Accumulated depreciation	(1,080.8)	(958.1)
Property and equipment, net	756	577.4
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,376.2	1,083.9
Land, buildings, and leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	312.4	306.2
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	116.5	114.5
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 31.7	$ 30.9

Supplemental Financial Inform_8

Supplemental Financial Information - Other Non-current Assets (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Other non-current assets:
Prepaid ship and debit	$ 547.6	$ 481.3
Technology licenses	350.6	439.5
Prepayments on supply capacity reservation agreements	$ 302.5	$ 282.3
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other non-current assets	Other non-current assets
Operating right-of-use assets	$ 203.6	$ 211.3
Non-marketable equity investments	45.8	36.1
Other	56.8	58.3
Other non-current assets	$ 1,506.9	$ 1,508.8

Supplemental Financial Inform_9

Supplemental Financial Information - Accrued Liabilities (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Accrued liabilities:
Variable consideration estimates	$ 610.7	$ 572.8
Technology license obligations	105.7	119.1
Accrued legal reserve	76.5	102
Deferred revenue	43.2	45.2
Accrued interest payable	41.3	22.1
Lease liabilities - current portion	39.4	43.8
Accrued warranty expense	25.5	2.4
Deferred non-recurring engineering credits	21.7	20
Accrued income tax payable	17.8	118.4
Other	51.1	46.2
Accrued liabilities	$ 1,032.9	$ 1,092
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities

Supplemental Financial Infor_10

Supplemental Financial Information - Other Non-current Liabilities (Details) - USD ($) $ in Millions	Feb. 03, 2024	Jan. 28, 2023
Other non-current liabilities:
Technology license obligations	$ 196.5	$ 267
Lease liabilities - non-current	196	201.6
Deferred tax liabilities	58.7	64.2
Non-current income taxes payable	56.6	28.5
Other	16.5	29.2
Other non-current liabilities	$ 524.3	$ 590.5
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities

Supplemental Financial Infor_11

Supplemental Financial Information - Changes in AOCI by Components (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	$ 15,637.2	$ 15,702.1	$ 8,435.8
Other comprehensive income, net of tax	1.1	0	0
Balance at end of period	14,831.4	15,637.2	15,702.1
Unrealized Gain (Loss) on Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	0	0
Other comprehensive income (loss) before reclassifications	(1.5)	(0.9)
Amounts reclassified from accumulated other comprehensive income (loss)	2.6	0.9
Other comprehensive income, net of tax	1.1	0
Balance at end of period	$ 1.1	$ 0	$ 0

Supplemental Financial Infor_12

Supplemental Financial Information - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Supplemental Cash Flow Information:
Cash paid for interest	$ 173.7	$ 147.9	$ 91.2
Cash paid for income taxes, net	120.6	95.9	7.9
Non-Cash Investing and Financing Activities:
Non-cash consideration paid and consideration unpaid for the acquisitions	0	9.2	7,231.8
Purchase of software and intellectual property under license obligations	56.2	108.9	325.5
Unpaid purchase of property and equipment at end of year	$ 80.1	$ 63.2	$ 20.7

SCHEDULE II - VALUATION AND Q_2

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Allowance for doubtful accounts
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 2.1	$ 3	$ 2.1
Additions	0.8	1.2	1.5
Deductions	(0.9)	(2.1)	(0.6)
Balance at End of Year	2	2.1	3
Deferred tax asset valuation allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	961.7	1,003.4	749.5
Additions	138.1	0	253.9
Deductions	(0.8)	(41.7)	0
Balance at End of Year	$ 1,099	$ 961.7	$ 1,003.4